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ABSTRACT: We provide a full account of our synthetic studies
targeting the hexacyclic calyciphylline B-type alkaloids, a
subfamily of the Daphniphyllum natural products. Following an
initial set of synthetic strategies focused on constructing the
piperidine core of the calyciphylline B-type framework via a 6π-
azaelectrocyclization, as well as exploiting the reactivity of
underexplored oxazaborinine heterocycles, we ultimately de-
signed a highly functionalized acyclic precursor which underwent
carefully orchestrated and efficient cyclizations to forge the
architecturally complex natural product scaffold. Our efforts have
culminated in the development of the first total synthesis of
(−)-daphlongamine H, provided access to its C5-epimer,
(−)-isodaphlongamine H, and led to structural revision of
deoxyisocalyciphylline B.
■ INTRODUCTION
The Daphniphyllum alkaloids are a large family of natural
products which exhibit a wide range of intriguing biological
activities, such as antioxidant and anticancer properties, as well
as promotion of nerve growth factor production.1 By virtue of
this pharmacological potential and the highly diverse and
complex azapolycyclic architectures of these compounds, they
have emerged as important total synthesis targets.2 Following
seminal work by Heathcock and co-workers on the
secodaphniphylline subset of these alkaloids,3 intense synthetic
efforts toward various other Daphniphyllum alkaloids were also
reported (Figure 1a). In the past decade, chemists have been
especially enticed by calyciphylline A-type and daphmanidin A-
type alkaloids, and elegant total syntheses of natural products
within this family were reported by the groups of Carreira,4 Li,5
Smith,6 Fukuyama,7 Dixon,8 Zhai,9 Qiu,10 Xu,11a and Gao.12
Recently, Xu and co-workers also completed total syntheses of
both a daphnezomine A-type11b and bukittinggine-type
alkaloid.11c
Calyciphylline B-type compounds belong to a small,
structurally distinct subclass among the 320 known Daphni-
phyllum alkaloids (Figure 1b). These secondary metabolites
feature a unique hexacyclic framework (rings A−F) containing
a central tertiary amine that is surrounded by seven contiguous
stereocenters. Following the discovery of the N-oxide parent
member, calyciphylline B,13 deoxycalyciphylline B (1),14 and
related congeners with differing C5/C6 configurations, such as
daphlongamine H (2),15 were isolated. In addition, two
calyciphylline B-type alkaloids with oxygenated E rings (4−
5),16 as well as two derivatives where the labile δ-lactone
moiety has undergone methanolysis, have been reported (6−
7).17 Biosynthetically, it is proposed that precursor A (Figure
1c), containing a tetrasubstituted olefin (ΔC5−C6) and
appended propionic acid side chain, might undergo non-
selective hydroacyloxylation to give four diastereomeric lactone
products.14,18 In this regard, Hanessian and co-workers
reported an elegant total synthesis of isodaphlongamine H
(3)19 and hypothesized that this compound was a “missing”
diastereomeric congener of the calyciphylline B-type alkaloids,
which had yet to be isolated from natural sources. Recently, we
accomplished the first total synthesis of (−)-daphlongamine H
(2)20 and revised the reported S-C6 configuration of
deoxyisocalyciphylline B to R-C6, thus revealing that
(−)-daphlongamine H (2) and isolated deoxyisocalyciphylline
B (2′) are effectively the same natural product. For the
calyciphylline B-type alkaloids (1−7), and on the basis of our
structural revision, only the natural occurrence of deoxycaly-
ciphylline B (1) and daphlongamine H (2) has been
unambiguously confirmed to date.
Compared to numerous other synthetic studies focusing on
Daphniphyllum alkaloids such as the calyciphylline A-type
alkaloids, the calyciphylline B-type subfamily has attracted
relatively little attention from the synthetic community.2b Prior
to and during the period of our own endeavor, the groups of
Hanessian and Beĺanger reported their synthetic studies on the
calyciphylline B-type alkaloids. Their strategies to access the
western tricyclic substructure are highlighted in Scheme 1. As
part of their studies, Hanessian and co-workers demonstrated
the convergent enolate alkylation of β-ketoester 8 with chiral
Received: August 14, 2019
Published: September 19, 2019
Article
pubs.acs.org/jocCite This: J. Org. Chem. 2019, 84, 14069−14091
© 2019 American Chemical Society 14069 DOI: 10.1021/acs.joc.9b02223
J. Org. Chem. 2019, 84, 14069−14091
D
ow
nl
oa
de
d 
vi
a 
U
N
IV
 O
F 
CA
LI
FO
RN
IA
 B
ER
K
EL
EY
 o
n 
Ju
ne
 4
, 2
02
0 
at
 2
2:
40
:4
3 
(U
TC
).
Se
e 
ht
tp
s:/
/p
ub
s.a
cs
.o
rg
/sh
ar
in
gg
ui
de
lin
es
 fo
r o
pt
io
ns
 o
n 
ho
w
 to
 le
gi
tim
at
el
y 
sh
ar
e 
pu
bl
ish
ed
 a
rti
cl
es
.
triflate 9.19 The resulting adduct was then elaborated to azide
10, which upon reduction to an amine group underwent
mesylate displacement to give the pyrollidine C ring. The
enaminone D ring of tricycle 11 was finally forged by a 1,4-
addition of the secondary amine onto a pre-installed ynone
moiety. The latter compound served as a key intermediate in
their elegant total synthesis of isodaphlongamine H (3). The
same group also reported detailed synthetic and computational
studies of their previous unsuccessful approaches. This
insightful report was particularly revealing in terms of the
challenges and difficulties encountered with respect to the
installation of the desired C7 stereochemistry.18 Ketone 12 was
converted to dienone 13, which underwent an aza-Michael
addition to form the piperidine D ring in 14, albeit bearing the
opposite C7 configuration relative to the one found in the
naturally occurring calyciphylline B-type alkaloids.
Beĺanger and co-workers have also reported creative
synthetic studies toward the western tricyclic substructure of
the calyciphylline B-type alkaloids. Their approach involved
preparation of cyclic silyl enol ether 15, which was elaborated
to tricyclic core structure 17 through a 1,3-dipolar cyclo-
addition of an in situ generated azomethine ylide via iminium
ion 16.21 While tricyclic core structure 17 was constructed
efficiently in this way, numerous redox manipulations appear
necessary to advance it to the calyciphylline B-type alkaloids.
Fascinated by the beautiful yet daunting architectures of the
calyciphylline B-type alkaloids, we also embarked on a
synthesis of these compounds. Herein, we disclose full details
of our synthetic journey that culminated in the first total
synthesis of (−)-daphlongamine H (2), gave access to its C5-
epimer, (−)-isodaphlongamine H (3), and led to a structural
revision of deoxyisocalyciphylline B (2′). We particularly
highlight how several initial approaches led to interesting
discoveries and insights that ultimately enabled an efficient and
successful synthetic route to construct the calyciphylline B-type
architecture.
■ RESULTS AND DISCUSSION
Initial Strategy. In an early synthetic plan (Scheme 2), it
was envisioned that the lactone and cyclopentane (rings A and
B) of the calyciphylline B-type alkaloids could be constructed
at a final stage from tetracyclic enaminone 18 via oxidation−
lactonization of the appended allyl group and an intra-
Figure 1. Calyciphylline B-type alkaloid subfamily.
Scheme 1. Previous Approaches to the Tricyclic Core of the
Calyciphylline B-type Alkaloids
Scheme 2. Initial Retrosynthetic Analysis
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molecular alkylation reaction, respectively. A central feature of
this retrosynthetic plan would involve assembly of 18 via an
ambitious cascade process. Specifically, in the forward sense,
we were enticed by the prospect of a suitable activation of
precursor N-allyl vinylogous amide 19, which would induce a
sequence entailing a formal [3,3] sigmatropic rearrangement
and a 6π-azaelectrocyclization22 to forge tetracyclic enaminone
18. Given the scant literature precedent associated with this
planned cascade, we reasoned that the sequence might at the
very least also be executable in a stepwise manner. N-Allyl
vinylogous amide 19 was traced back to hydro-indene 20 and
alkyne 21 as reactants for a convergent union through
Sonogashira coupling. In turn, enantiomerically enriched 20
would be derived from 5-methoxyindane (22), while 21 could
be obtained via elaboration of known α,β-unsaturated lactone
23.23
As outlined in Scheme 3, preparation of alkyne 29 began
with conjugate addition of an acetylide equivalent to α,β-
unsaturated lactone 23. While copper and aluminum acetylides
failed to undergo this desired transformation, the Rh-catalyzed
method introduced by Hayashi,24 using silanol 24 to generate a
rhodium acetylide species in situ, proved successful in
furnishing disubstituted lactone 25 in 51% yield. The latter
compound was then subjected to Weinreb amide formation to
provide a primary alcohol which upon mesylation furnished 26.
Following a two-step reduction, alcohol 27 was obtained in
89% yield. This more lengthy synthetic sequence was adopted
because the initially planned direct conversion of disubstituted
lactone 25 to alcohol 27, via reduction and subsequent
differentiation of the two primary hydroxy groups, did not
proceed with satisfactory selectivity. Next, protecting group
manipulations gave silyl ether 28 which readily underwent
mesylate displacement with allylamine to give an intermediate,
unstable, secondary amine that was converted to trifluoroacetyl
protected alkyne 29.
For the synthesis of the enantiomerically enriched hydro-
indene substructure (EF rings), we explored Birch reduction of
anisole 22 (Scheme 4) followed by mild hydrolysis of the
resulting enol ether25 to give β,γ-unsaturated ketone 30.
According to Deng’s method for the enantioselective isomer-
ization by cooperative iminium-base catalysis,26 30 was treated
with cinchona alkaloid-derived organocatalyst QD to give
enone 31. The best selectivity in this transformation was
achieved by addition of (R)-2-chloropropionic acid as a co-
catalyst and use of chloroform as the solvent. Even though the
optical purity of enone 31 remained mediocre (57% ee)
despite our optimization attempts,27 we reasoned that it would
suffice for our preliminary studies. Particularly, because the
hydro-indene bicycle would be combined with an enantiomeri-
cally pure building block (i.e., alkyne 29), a resolution would
be achieved at a later stage. The subsequent preparation of γ-
dienol triflate 32 from enone 31 proved nontrivial because of
an accompanying erosion of optical purity, as well as the
competing formation of undesired and inseparable α- and γ′-
dienol triflate isomers. A thorough investigation of various
enolization conditions finally revealed that employing a
substoichiometric amount of KHMDS enabled the selective
generation of dienol triflate 32.27 It is hypothesized that under
these optimized reaction conditions, the kinetic α-dienolate
equilibrates to the desired γ-dienolate prior to triflation.
Palladium-catalyzed carbonylation,28 followed by hydrolysis
of the intermediate acid chloride, then provided carboxylic acid
33 in 75% yield. At this stage, chiral HPLC analysis of 33 (53%
ee) confirmed that only minimal erosion of optical purity had
taken place in the preceding, optimized triflation of enone
31.29
Scheme 3. Synthesis of Alkyne 29a
aReagents and conditions: (a) 24, [RhCl(cod)]2, Cs2CO3, PhMe, 80
°C (51%); (b) Me(OMe)NH·HCl, iPrMgCl, THF, 0 °C; (c) MsCl,
NEt3, CH2Cl2, 0 °C (76%, 2 steps); (d) LiAlH4, THF, 0 °C; (e)
NaBH4, CH2Cl2, MeOH, 0 °C (89%, 2 steps); (f) TBAF, THF, 0 °C;
(g) TBSCl, imidazole, CH2Cl2, 0 °C (99%, 2 steps); (h) allylamine,
NaI, NEt3, MeCN, 45 °C; (i) TFAA, NEt3, CH2Cl2, −78 °C (79%, 2
steps). TIPS = triisopropylsilyl, THF = tetrahydrofuran, cod = 1,5-
cyclooctadiene, Ms = CH3SO2, TBAF = tetrabutylammonium
fluoride, TBS = tert-butyldimethylsilyl, TFAA = trifluoroacetic
anhydride.
Scheme 4. Synthesis of Enantiomerically Enriched
Carboxylic Acid 33a
aReagents and conditions: (a) Li, NH3 (l), THF, −78 to −40 °C,
then EtOH, −40 to 23 °C; (b) oxalic acid, MeOH, H2O, 0 °C; (c)
QD (15 mol %), (R)-2-chloropropionic acid (30 mol %), CHCl3, −20
°C (50%, 57% ee); (d) KHMDS, THF, −15 to 23 °C, then PhNTf2, 0
°C (85%); (e) CO (g), Pd(OAc)2, TBACl, pyridine, DMF, 60 °C
(75%, 53% ee). KHMDS = potassium bis(trimethylsilyl)amide, Tf =
CF3SO2, TBACl = tetrabutylammonium chloride, DMF = N,N-
dimethylformamide.
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Having secured access to both building blocks for the
convergent coupling, the synthesis of the key step precursor
(cf. 19, Scheme 2) was pursued (Scheme 5a). To this end,
carboxylic acid 33 was converted to the corresponding acid
chloride (34) and subjected to Sonogashira coupling with
alkyne 29.30 The intermediate alkynone was treated with
K2CO3 in methanol to remove the trifluoroacetate group and
reveal the secondary amine (35) which underwent aza-Michael
addition to give N-allyl vinylogous amide 36. The latter
compound features the nor-carbon framework of all calyciphyl-
line B-type alkaloids and was obtained as an inseparable
mixture of diastereomers (∼3:1 d.r. at C10), as a result of the
mediocre enantiomeric purity of coupling partner 34.
Unexpectedly, NMR analysis (NOESY) of vinylogous amide
36 revealed that the C2 stereocenter had inverted after the aza-
Michael reaction to give the resulting pyrrolidine substructure
bearing trans-disposed substituents. We were unable to avoid
this spontaneous and thermodynamically favored epimeriza-
tion, which readily took place as it alleviates steric strain
induced by the syn-orientation of the substituents. Cognizant
that the undesired C2 configuration of 36 would have to be
corrected at a later stagea transformation which we believed
should be achievable by kinetic γ-deprotonation and
protonationwe aimed to identify suitable activation of N-
allyl vinylogous amide 36 to forge tetracyclic enaminone 39 via
the formal [3,3] rearrangement and 6π-azaelectrocyclization
(cf. 37 and 38). Initially focusing on the first step of this
ambitious key cascade, it was soon established that the planned
[3,3] sigmatropic rearrangement was challenging. This circum-
stance was further corroborated by very limited existing
literature precedent for the formal [3,3] rearrangement of N-
allylic enaminones,31 in contrast to the related aza-Claisen
variant involving enamine substrates.32,33 After careful
experimentation, we were pleased to discover that treatment
of N-allyl vinylogous amide 36 with the specific combination of
triethylborane, palladium(II) acetate, triphenylphosphine, and
pyridinium p-toluenesulfonate gave rise to the [3,3] rearranged
product which was isolated as the corresponding oxazaborinine
40 in 78% yield. At this stage, we recognized the utility of this
powerful and highly efficient transition-metal-catalyzed ox-
azaborinine synthesis and devised an independent method-
ology to explore the scope of this novel discovery.34 While
oxazaborinines are valuable structural motifs that have found
applications in research ranging from materials chemistry35 to
pharmaceutical development,36,37 we were especially interested
in investigating the unique and underexplored reactivity of
these boron heterocycles for use in complex molecule
synthesis. For example, the oxazaborinine moiety can serve
as a remarkably stable protecting group for the vinylogous
amide and can be removed with organolithium reagents or by
treatment with aqueous acid.
As outlined in Scheme 5b, model oxazaborinine 42 was
converted to tricycle 43 via cleavage of the boron heterocycle
to reveal the vinylogous amide that underwent 6π-azaelec-
trocyclization at elevated temperature.29 Disappointingly,
translation of this reaction sequence to the conversion of
oxazaborinine 40 to the desired tetracyclic enaminone (39)
proved unsuccessful (Scheme 5a). Hydrolysis of the boron
heterocycle in 40 under a variety of conditions gave rise to
only trace amounts of the corresponding α-allyl vinylogous
amide and mostly resulted in complex product mixtures and
nonspecific decomposition.
Modified Oxazaborinine Approach. Our ability to
assemble a model system of the calyciphylline B-type alkaloid
core (i.e., 43), by means of a formal [3,3] rearrangement and a
subsequent 6π-azaelectrocyclization, convinced us that this
conceptual strategy was worth further pursuit. However, at this
juncture, we envisioned a modified synthetic sequence that
would avoid the problematic epimerization of the C2
stereocenter and also allow us to exploit the unique reactivity
of the oxazaborinine heterocycle for constructing the
calyciphylline B-type core structure (Scheme 6). While the
endgame disconnection for the lactone moiety would remain
identical, a diastereoselective reduction of pentacyclic enamine
44 was envisioned to give the all-cis substituted pyrrolidine
substructure. We considered two distinct strategies to access
44 from either enaminone 45 or haloimine 46, both of which
could arise from cyclopropyl oxazaborinine 47. In the former
pathway, the B ring of 44 would result from a vinyl-
cyclopropane rearrangement (VCPR)38 of enaminone 45,
Scheme 5. Synthesis of Oxazaborinine 40 and Attempted
Key Cascade Reactiona
aReagents and conditions: (a) (COCl)2, DMF, CH2Cl2, 0 to 23 °C;
(b) 29, CuI, PdCl2(PPh3)2, NEt3, 23 °C; (c) K2CO3, MeOH, THF,
H2O, 23 °C (68%, 3 steps, 3:1 d.r. at C10); (d) BEt3, Pd(OAc)2,
PPh3, PPTS, PhMe, 80 °C (78%, 3:1 d.r. at C10); (e) BEt3,
Pd(OAc)2, PPh3, PPTS, PhMe, 80 °C (95%); (f) MeLi, THF, −78 to
0 °C (70%); (g) TBSCl, NEt3, PhMe, 110 °C (42% trans-43; 44% cis-
43). PPTS = pyridinium p-toluenesulfonate.
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itself being derived from 47 via the established hydrolysis and
6π-azaelectrocyclization sequence. It was postulated that the
activated nature of the system would enable the VCPR in 45
under significantly milder conditions compared to the classical
variant,39 which often requires temperatures exceeding 350 °C.
With the advent of methods for C−C activation in strained
ring systems,40 we anticipated that a formal VCPR might also
be feasible by employing transition-metal catalysis. With
respect to the alternative pathway, the central ring of
pentacyclic enamine 44 would be forged from haloimine 46
through halide ring opening of the activated cyclopropane,41
an aza Michael reaction, and reductive coupling of the resulting
dihalide.42 We anticipated utilizing the established conditions
for α-halogenation of oxazaborinines to access haloimine 46.34
The synthesis of cyclopropane containing oxazaborinine 47
began with preparation of a new alkyne Sonogashira coupling
partner (Scheme 7). Initially, we attempted to install the C18
stereocenter using an enantioselective hydroboration43 of
alkene 49 to give alcohol 50 following oxidation of the
intermediate pinacolboronate. While the synthesis of alkene 49
from tosylate 48 was efficient using Fürstner’s iron-catalyzed
cross-coupling protocol for tert-alkyl electrophiles,44 the
subsequent hydroboration−oxidation was very low yielding.29
Therefore, we turned instead to an auxiliary-based approach
and prepared cyclopropyl acid 51 for an ensuing Evan’s
asymmetric enolate alkylation to give oxazolidinone 52.45
Following reduction of the imide, mesylation of the resulting
primary hydroxy group and removal of the trimethylsilyl group
gave alkyne 53 which underwent coupling with acid chloride
34 to furnish alkynone 54 in 97% yield. Displacement of the
mesylate with allyl amine, followed by aza-Michael reaction,
delivered the cyclopropyl containing vinylogous amide 55 in
low yield together with numerous unidentified side products.
Alternatively, cyclopropyl vinylogous amide 55 was accessed
via amide 56. However, 55 was obtained in comparable overall
yield through the latter route, and we concluded that the
product itself was somewhat unstable. Nevertheless, we were
able to acquire sufficient quantities of 55 to begin investigating
the key step.
Subjecting cyclopropyl vinylogous amide 55 to the
established conditions for oxazaborinine synthesis gave 47 in
60% yield (Scheme 8). Presumably, as a result of the increased
steric congestion at the γ-quaternary center in this substrate,
the transformation was accompanied by formation of some
deallylated oxazaborinine side product (10−20%).34 Pursuing
our plan to use an α-haloimine intermediate for construction of
pentacyclic enamine 44 (cf. 46 in Scheme 6), conversion of
cyclopropyl oxazaborinine 47 to haloimine 57 was attempted.
Unfortunately, under various conditions (e.g., NCS; NBS;
PIFA; and TMSCl), the masked boron enolate in 47 failed to
undergo the desired α-halogenation and either unreacted
starting material was recovered or nonspecific decomposition
took place. We thus turned our attention to the envisioned
VCPR and 6π-azaelectrocyclization sequence, and after
considerable experimentation discovered that oxazaborinine
47 could be hydrolyzed in boiling ethanol in the presence of
DMAP. Activation of the resulting α-allyl vinylogous amide at
elevated temperature with a mild Lewis acid led to formation
of a cyclized product with the desired N−C7 bond. Yet to our
frustration, closer NMR analysis revealed that the product of
the 6π-azaelectrocyclization had undergone spontaneous
oxidation to give 4-pyridone 58. Recognizing that the
Scheme 6. Revised Retrosynthesis Using Cyclopropyl
Oxazaborinine 47
Scheme 7. Synthesis of Cyclopropyl Vinylogous Amide 55a
aReagents and conditions: (a) H2CC(CH3)MgBr, Fe(acac)3, THF,
−30 °C (92%); (b) HBpin, CuCl, KOtBu, (S)-(+)-5,5′-Bis[di(3,5-di-
tert-butyl-4-methoxyphenyl)phosphino]-4,4′-bi-1,3-benzodioxole,
PhMe, 23 °C; (c) Na2BO4, THF, H2O, 23 °C (9%); (d) PivCl, NEt3,
THF, −78 to 0 °C then (premixed) n-BuLi, (S)-4-benzyl-2-
oxazolidinone, −78 to 23 °C (80%); (e) NaHMDS, MeI, THF,
−78 to 0 °C (79%); (f) LiBH4, THF, MeOH, 0 °C (95%); (g) MsCl,
NEt3, CH2Cl2, 0 °C; (h) TBAF, THF, 0 °C (96%, 2 steps); (i)
allylamine, NaI, NEt3, MeCN, 45 °C; (j) TFAA, NEt3, CH2Cl2, −78
°C (57%, 2 steps); (k) 34, CuI, PdCl2(PPh3)2, NEt3, 23 °C; (l)
K2CO3, MeOH, THF, H2O, 23 °C (40%, 2 steps, 3:1 d.r. at C10);
(m) 34, CuI, PdCl2(PPh3)2, NEt3, 23 °C (97%, 3:1 d.r. at C10); (n)
allylamine, NEt3, MeCN, 60 °C (25%, 3:1 d.r. at C10). acac =
acetylacetone, pin = pinacol, Piv = (CH3)3CO, NaHMDS = sodium
bis(trimethylsilyl)amide.
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undesired oxidation of the dihydropyridone intermediate
might be challenging to avoid under the harsh conditions
required for the 6π-azaelectrocyclization, we attempted to
carry out the VCPR prior to formation of the N−C7 bond.
Disappointingly, the VCPR could not be induced in neither
55 nor 47 under a variety of thermal, photochemical, Lewis
acid [e.g., Et2AlCl, MgI2, BF3·Et2O, CuBr2, Zn(OTf)2,
Yb(OTf)3] or transition-metal (Rh, Ni, Pd)-based activation
methods.
New Strategy. In light of the difficulties encountered in
attempting to form the key N−C7 bond in our oxazaborinine
approaches, we began contemplating an entirely different
synthetic strategy. At this stage, we also decided to abandon
the convergent fragment coupling concept, as efficient
installation of the remote C10 stereocenter in the hydro-
indene building block could not be achieved, and its use in
mediocre enantiomeric purity had proven unsatisfactory. In the
new route design, particular emphasis was placed on concise
construction of the synthetically challenging, western all-cis 1-
H/2-H/18-H substructure. With this in mind, the calyciphyl-
line B-type framework was traced back to enyne 59 as the
precursor for forming the hydro-indene substructure via a late-
stage Pauson−Khand reaction (Scheme 9). In turn, tricycle 60
would constitute a key intermediate of the synthetic route,
wherein the piperidinedione motif, readily derived from bicycle
61 via Dieckmann condensation, would serve as a versatile
handle for installation of the C5−C7 substituents. We
envisioned the all-cis methine substructure in 61 to result
from an intramolecular Heck−Suzuki coupling cascade and
diastereoselective hydrogenation. Thus, 61 was traced back to
bifunctional β-amino ester 62 that contains the retron for an
asymmetric aza-Michael reaction.
While a range of homochiral lithium amides derived from α-
methylbenzylamine have been reported to undergo diaster-
eoselective conjugate addition to α,β-unsaturated esters,46 it
was unclear at the outset of our investigations whether a
sensitive vinyl bromide moiety in the lithium amide would be
tolerated (Scheme 10). Fortunately, the conjugate addition of
the lithium amide derived from 63 to pentadienoate 64 was
rendered successful at low temperature along with careful
control of the reaction time. These conditions proved critical
in avoiding β-elimination of the vinyl bromide to give
undesired propargylamine side products.47 Next, β-amino
ester 65 was α-methylenated in one pot by sequential
alkylation and elimination to furnish enoate 66. Before
investigating the planned Heck−Suzuki cascade, we also
explored if, albeit typically disfavored,48 a 5-exo-trig/5-endo-
trig sequence might allow direct conversion of enoate 66 to a
bicyclic substructure reminiscent of 70. However, the desired
transformation could not be achieved under radical or Heck-
type conditions.49 Returning to the original plan, 66 was
subjected to copper-catalyzed β-borylation, according to
Molander’s protocol,50 to furnish boronic acid 67, which was
treated with a catalytic amount of Pd(PPh3)4 and aqueous
Na2CO3 in tetrahydrofuran (THF) at elevated temperature.
Although successful, the ensuing Heck−Suzuki cascade
frustratingly gave rise to trans-bicycle 70 and trace amounts
of the corresponding C8 epimer,29 without detection of any of
the desired cis-bicycle. The stereochemical outcome of this
transformation had been difficult to deduce with certainty,
given the multitude of rotational isomers of precursor 67. In
retrospect, we ascribe steric interactions of the vinyl group to
favor conformer 69 over 68, which results in formation of the
undesired trans-1-H/2-H configured product 70.
While we had demonstrated the viability of a C−C bond
construction from the amine-appended vinyl bromide in 67,
we recognized that prior formation of the B ring would be
required to overcome formation of the undesired trans-ring
junction. Consequently, β-amino ester 65 was sequentially α-
allylated and subjected to ring-closing metathesis to furnish
cyclopentene 71 (Scheme 10). As anticipated, the intra-
molecular Heck coupling proceeding via 72 now furnished
bicyclic substructure 73 possessing the desired cis-1-H/2-H
configuration. To access a saturated bicycle such as 74 from
73, we investigated the diastereoselective hydrogenation,
removal of the chiral auxiliary and installation of the α-
quaternary center in the subsequent synthetic steps. Dis-
appointingly, none of these transformations, executed in
various orders, proved satisfactory. Removal of the methyl-
benzyl group proved unexpectedly challenging and could not
be carried out with dissolving metal reductions, which led to
complex product mixtures or decomposition. Alternatively,
forcing, heterogeneous hydrogenations gave low yields of the
corresponding saturated secondary amine, albeit as an
inseparable diastereomeric mixture at C18 (∼1:1 d.r.). Prior
Scheme 8. Synthesis of Cyclopropyl Oxazaborinine 47 and
Attempted Conversion to Pentacyclic Enamine 44a
aReagents and conditions: (a) BEt3, Pd(OAc)2, PPh3, PPTS, PhMe,
80 °C (60%, 3:1 d.r. at C10); (b) DMAP, EtOH, 80 °C; (c) N,O-
bis(trimethylsilyl)acetamide, DMF, 130 °C (10%, 2 steps, 1.5:1 d.r. at
C10).
Scheme 9. Retrosynthetic Analysis of the Calyciphylline B-
type Framework Based on Key Tricycle 60
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saturation of the bicyclic structure via potentially more
selective, homogeneous hydrogenation methods failed, pre-
sumably because of the presence of the basic tertiary amine.
Furthermore, following numerous attempts to alkylate 73 (and
derivatives thereof) using a variety of bases and electrophiles,
installation of the α-quaternary center also remained
unsuccessful.
Although having failed to further elaborate bicycle 73, the
auspicious bond constructions to build the bicycle that
comprises the western portion of the calyciphylline B-type
alkaloids had provided a lot of insight for revising the synthetic
plan. Notably, we became cognizant of the importance of
embedding the nitrogen as an amide, rather than amine, to
enable an efficient diastereoselective hydrogenation. Further-
more, we were also encouraged to introduce the quaternary
center earlier in the synthesis, thus circumventing a late-stage
and challenging alkylation.
Mannich Approach.20 At this stage, we envisioned a
revised synthetic strategy to access tricycle 60 involving similar
cyclization events as in the previous strategy (Scheme 11).
However, as a major difference, acyclic β-amino ester 75 would
incorporate the C8 quaternary center. While 75 contains the
obvious retron for a Mannich reaction, literature precedent for
the intermolecular enantio- and diastereoselective preparation
of α,α-dialkylsubstituted Mannich products is scarce
particularly when the two α-substituents in the acyclic
pronucleophile are nonequivalent.51 The pertinent reported
examples generally involve use of activated glyoxylate-derived
imines,52 hence making those methods less favorable for our
goal to access 75 in a concise manner. Inspired by Ellman’s
pioneering work,53 we eventually decided to construct β-amino
ester 75 from allylated valerolactone 7654 and N-tert-
butanesulfinyl imine 77.55 Cursory examination of the
parameters for this transformation had shown that the γ-
substituent in the imine would be required to avoid undesired
1,4-addition of the enolate.29 While we faced some uncertainty
regarding the diastereoselectivity at the α-quaternary center in
this Mannich reaction, we reasoned that the choice of these
particular substrates would be ideal in terms of accessing a
suitably functionalized and oxidized product for rapid
conversion to 75. Moreover, the very high degree of molecular
complexity generated in this Mannich reaction, namely, the
construction of a key C−C bond with both the α-quaternary-
and β-amino centers, would outweigh a potentially imperfect
diastereoselectivity at the quaternary center.
In practice and as expected, addition of the lithium enolate
derived from 76 to sulfinyl imine 77 gave rise to a mixture of
the epimeric Mannich products SS-80 and SR-80 (Scheme 12).
However, the distribution of these β-amino lactone products
was strongly influenced by the reaction temperature and time.
Following optimization studies, we realized that this trans-
formation encompassed a Mannich−retro-Mannich equilibra-
tion of the product β-amino lactones, where SS-80 appeared to
be the kinetic product that was obtained nearly exclusively
following a short reaction time.27 According to a Zimmerman−
Traxler-type six-membered transition-state model,53 we ration-
alized that SS-80 and SR-80 were formed via 78 and 79, where
either the allyl or lactone methylene group adopt a pseudo-
axial disposition, respectively. Given the similar steric influence
exerted by these two groups, we expected that under
thermodynamic reaction conditions, a virtually equal distribu-
tion of the β-amino lactone products would be obtained.
Scheme 10. Synthesis of trans-Bicycle 70 and cis-Bicycle 73a
aReagents and conditions: (a) n-BuLi, THF, −78 °C then 64 (66%); (b) LDA, THF, −78 °C then MEMCl, 0 °C then KOtBu, 23 °C (50%); (c)
(B(OH2)2, CuCl, (2-biphenyl)dicyclohexylphosphine, NaO
tBu, EtOH, 23 °C; (d) Pd(PPh3)4, Na2CO3, THF, H2O, 70 °C (27% 70, 3% C8-epi-
70); (e) LDA, THF, −78 °C then allyl bromide, 0 °C; (f) Hoveyda−Grubbs 2nd gen catalyst, CH2Cl2, 40 °C (72%, 2 steps); (g) Pd(OAc)2, PPh3,
NEt3, MeCN, 80 °C (55%). LDA = lithium diisopropylamide, MEMCl = 2-methoxyethoxymethyl chloride, Ac = CH3CO.
Scheme 11. Revised Retrosynthetic Analysis of Tricycle 60
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Indeed, following further experimentation, β-amino lactones
SS-80 and SR-80 were ultimately formed as a ∼1:1 mixture in
82% combined yield on multigram scale.
Turning to the tricyclic core construction, we intended to
utilize both β-amino lactones SS-80 and SR-80 in the forward
synthesis (Scheme 13). With respect to use of SS-80, a formal
inversion of the C8 stereocenter was envisioned that would
then enable us to intercept the SR-synthetic route. First, the
sulfinyl group in SR-80 was removed with concomitant lactone
methanolysis to give, after N-alkylation of the intermediate
hydrochloride salt, vinyl bromide 81. Following silylation and
acetylation, amide 82 underwent sequential ring-closing
metathesis and Dieckmann condensation to give decagram
quantities of vinyl bromide-bearing bicycle 84. Starting from β-
amino lactone SS-80, a related synthetic sequence furnished
amide 83, whereupon a variety of attempts were made to
formally invert the C8 stereocenter via anti-Markovnikov
hydration of the allyl group and elimination of the C22
hydroxy group. In practice, numerous variants of hydro-
boration−oxidation, Wacker-type oxidation, oxidative cleav-
age−homologation, or silylation followed by Fleming−Tamao
oxidation that were investigated proved unsuccessful in
achieving the desired functionalization of the terminal olefin.29
We suspect that the underlying, very densely and diversely
functionalized, nature of amide 83 led to the many failed
oxidation attempts, and we were unable to pinpoint any exact
factors for this circumstance. Consequently, our plan to use SS-
80 in the synthetic route was abandoned, but the material
could be recycled via retro-Mannich reaction to furnish imine
77 and allylated lactone 76.29 Returning to vinyl bromide
bearing bicycle 84, an intramolecular Heck coupling completed
construction of the tricyclic substructure and furnished diene
85 in 72% yield. Alternatively, the tricyclic framework of 86
featuring a saturated B-ring could be accessed by means of a
reductive radical cyclization. It was discovered that radical
initiation with BEt3/O2 and use of Bu3SnH as the reductant
provided dehydro tricycle 86 in the highest yield on multigram
scale.27 Notably, a similar radical ring closure had not been
successful in related substrates containing a tertiary amine
instead of an amide (cf. 66 and 71, Scheme 10).
With the tricyclic framework in place, our focus transitioned
to completion of the challenging all-cis 1-H/2-H/18-H
substructure (Scheme 14). While heterogeneous hydrogena-
tions of diene 85 gave rise to complex mixtures of products, a
two-step protocol using Crabtree’s catalyst for reduction of the
1,1′-disubstituted alkene, followed by Pd/C-catalyzed hydro-
genation of ΔC3−C4, ultimately afforded tricycle 87, albeit as
a 4:1 mixture of diastereomers over a reaction time that
exceeded 1 week. Fortunately, dehydro tricycle 86 emerged as
a far more favorable substrate for the diastereoselective
hydrogenation, especially because its saturated B-ring created
a sterically more biased concave face. In this respect, reaction
optimizations revealed the use of the Pd(OH)2 catalyst at
reduced hydrogen pressure to be ideal, which gave access to
tricycle 87 in excellent diastereoselectivity.27 A survey of
various solvents identified dichloromethane to be unique in
enabling rapid initial isomerization of the exo-olefin to enamide
88, prior to hydrogenation. The optimized route to 87,
proceeding in nine overall steps, provided multigram scale
access to the tricyclic substructure containing four contiguous
stereocenters.
Next, the diastereoselective installation of the C5−C7
substituents in the piperidinedione substructure was inves-
tigated (Scheme 15a). Alkylation of the 1,3-dicarbonyl system
Scheme 12. Optimization of the Mannich Reactiona
aReagents and conditions: LDA, 76, THF, −78 °C, then 77 (44%,
53% brsm SS-80; 38%, 45% brsm RS-80).
Scheme 13. Synthesis of the Tricyclic Corea
aReagents and conditions: (a) 4 M HCl in 1,4-dioxane, MeOH, 50
°C; (b) 2,3-dibromopropene, iPr2NEt, CH3CN, 80 °C, (77%, 2 steps,
+11% from 2nd cycle); (c) TBSCl, imidazole, CH2Cl2, 0 to 23 °C
(89%); (d) Ac2O, PhH, 90 °C (96%); (e) Hoveyda−Grubbs 2nd gen
catalyst (HG II), CH2Cl2, 40 °C (82%); (f) LiHMDS, THF, −78 °C
(90%); (g) 4 M HCl in 1,4-dioxane, MeOH, 0 to 23 °C; (h) 2,3-
dibromopropene, iPr2NEt, CH3CN, 80 °C, (54%, 2 steps, +17% from
2nd cycle); (i) AcCl, iPr2NEt, DMAP, CH2Cl2, 23 °C (85%); (j)
Pd(OAc)2, PPh3, NEt3, MeCN, 50 °C (72%); (k) Bu3SnH, Et3B, O2,
PhH, 23 °C (91%). DMAP = N,N-dimethylaminopyridine, AIBN =
azobisisobutyronitrile.
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in 87 was complicated by formation of di-, C-, and O-alkylated
product mixtures using a wide variety of base (K2CO3,
Cs2CO3, LiHMDS, NaH, NaO
tBu, and KOtBu) and solvent
[THF, acetone, PhMe, N,N-dimethylformamide (DMF),
DMSO, tBuOH, MeCN, and NMP] combinations. Eventually,
we identified homoallyl iodide to exhibit a marked improve-
ment in terms of C-selectivity in DMF solvent, compared to
the corresponding bromide, and the resulting product was
obtained in 62% yield. For the ensuing conversion to
enaminone 90, we initially explored transient protection of
the ketone as the enolate or silyl enol ether, followed by
treatment with various metal hydrides to reduce the δ-lactam.
However, hydride additions to this electron-rich system proved
unsuccessful and led us instead to seek a direct, amide-selective
reduction of the 1,3-dicarbonyl system. Following a survey of a
wide range of existing methods,56 only Dixon’s reported
combination of Vaska’s complex and TMDS was successful in
selectively reducing the lactam amide in the presence of both
the ketone and very sensitive terminal olefin groups.8,57
Surprisingly, the analogous reduction prior to introduction
of the homoallyl group (i.e., reduction of tricycle 87) was
unsuccessful, suggesting that the terminal olefin might act as an
auxiliary directing group in this remarkably chemoselective
transformation (see 89).
Addition of ethynylmagnesium bromide to the triflate salt
derived from enaminone 90 took place from the sterically less
encumbered α-face and furnished the intermediate silyl enol
ether, 91, as a single diastereomer. While exposure of the latter
compound to TBAF furnished C6-epimeric enynes 92 and 93
in a ∼1:2 ratio, acid hydrolysis afforded cis-enyne 92 as the
major product (3.6:1 d.r.). This stereochemical outcome can
be rationalized by the (kinetically) favored protonation
occurring from the more accessible face that is cis to 7-Hβ.
Methyl addition to the carbonyl group in 92 then occurred
exclusively from the β-face (94), by virtue of the preferred
Scheme 14. Diastereoselective Hydrogenation of the
Tricyclic Frameworka
aReagents and conditions: (a) 50 atm H2, [Ir(cod) (PCy3) (py)]PF6,
CH2Cl2, 23 °C; (b) 1 atm H2, Pd/C, NaHCO3, MeOH, 23 °C (58%,
2 steps, 4:1 d.r.); (c) 1 atm H2/Ar (1:1), Pd(OH)2, CH2Cl2, 23 °C,
(87%, ≥20:1 d.r.).
Scheme 15. Elaboration of Tricyclic Core 87 and Construction of the Full Calyciphylline B-type Carbon Frameworka
aReagents and conditions: (a) NaH, 4-iodo-butene, DMF, 0 °C (62%, 72% brsm); (b) TMDS, [IrCl(CO) (PPh3)2], PhMe, 23 °C (73%, +13%
from 2nd cycle); (c) TMSOTf, CH2Cl2, −78 °C, then HCCMgBr, THF, −78 to 0 °C, then aq 6 M HCl, 0 to 23 °C (62% 92; 17% 93); (d) 92,
LaCl3·2LiCl, THF, 23 °C, then MeLi, −25 °C (94%, ≥20:1 d.r.); (e) Co2(CO)8, CH2Cl2, 23 °C, then MeCN, TMANO·2H2O, −78 to 23 °C
(59% 97; 5% 98); (f) Co2(CO)8, CH2Cl2, 23 °C, then TMANO·2H2O, 0 to 23 °C; (g) TBSCl, imidazole, CH2Cl2, 23 °C (69%, 2 steps). TMDS =
1,1,3,3-tetramethyldisiloxane, TMS = trimethylsilyl, TMANO = trimethylamine N-oxide. bTBS omitted for clarity.
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nucleophile trajectory being cis to 6-Hβ. Notably, the
lanthanum(III) chloride bis(lithium chloride) complex was
identified as an essential additive to achieve appreciable
conversion in this transformation.58 Enyne diol 95 underwent
amine-N-oxide-promoted Pauson−Khand reaction59 to furnish
pentacyclic enone 97 together with trace amounts of enol ether
98, as a consequence of competing hydroalkoxylation of the
alkyne moiety. The cis-enyne disposition had resulted in a
corresponding insertion of the cobalt complex to the appended
olefin group (96) to install 10-Hα in the desired orientation. It
was corroborated that the C5 tertiary hydroxy group does not
influence the generated C10 stereocenter, as Pauson−Khand
reaction of cis-enyne 92 (prior to methyllithium addition) gave
rise to the same 10-Hα orientation. Having also gained access
to trans-enyne 93, featuring the S-C6 configuration that is
present in deoxycalyciphylline B (1), analogous construction of
the E and F rings was investigated (Scheme 15b).
Unfortunately, subjecting 93 to sequential Pauson−Khand
reaction (99) and silylation of the primary hydroxy group gave
enone 100 whose undesired C10 stereochemistry was
confirmed by single-crystal X-ray analysis. We were unable to
alter this stereochemical outcome, and attempts to epimerize
10-Hβ in enone 100 via γ-deprotonation or siloxydiene
formation were met with failure, leading us not to pursue a
synthesis of deoxycalyciphylline B (1).
With the full carbon framework of the calyciphylline B-type
natural products in place, we discovered that treatment of
enone 97 with excess sodium cyanoborohydride in the
presence of boron trifluoride diethyl etherate60 cleanly
furnished the corresponding cyclopentene (Scheme 16). This
highly efficient one-step deoxygenation protocol proved far
superior to other methods that were investigated (such as
Wolff−Kishner-, Clemmensen-type reductions, dithiane for-
mation/Raney Ni, or LiAlH4/AlCl3).
61 The cis-lactone was
finally installed via Jones oxidation and completed the total
synthesis of isodaphlongamine H (3), which displayed
analytical data in excellent agreement with Hanessian’s
report.19
For the synthesis of daphlongamine H (2), we were
challenged to invert the tertiary alcohol in 97. The strong
steric bias in the precursor carbonyl derivative (i.e., enyne 92)
had prevented us from accessing the opposite configuration at
C5 by addition of different methyl nucleophiles. Consequently,
we pursued a formal dehydration−rehydration sequence on
enone 97 which was initiated with the synthesis of alkene 101.
Subjecting the exocyclic alkene to Mn- and Co-catalyzed
radical hydrofunctionalizations62 returned either unreacted
starting material or led to nonspecific decomposition, and 102
could not be accessed. Various other conventional methods
(such as oxymercuration, m-CPBA epoxidations, dihydrox-
ylation, or halohydrin formation) were equally unsuccessful in
oxygenating the exomethylene in 101. Ultimately, trifluoroper-
acetic acid enabled oxidation of the sterically hindered alkene
in the presence of the proximal tertiary amine63 and furnished
epoxide 103, albeit in 35% yield. Next, epoxide 103 was
reduced with lithium aluminum hydride to give an
intermediate triol that was subjected to the established
deoxygenation conditions. After oxidation of the resulting
amino diol, the lactonization of the resulting highly polar trans-
seco acid 104 proved unexpectedly challenging. We noted that
for formation of the highly strained trans-lactone in 2, in
comparison to the facile cis-lactonization in isodaphlongamine
H (3), the central piperidine ring would need to undergo a
drastic conformational change to place the C5-hydroxy group
in a pseudo-equatorial orientation. While mildly acidic
conditions or simple thermal activation of 104 did not afford
any desired lactone product, we discovered that cyanuric
chloride was a suitable promoter of the final bond formation.64
This successful trans-lactone formation is probably driven by a
double activation of the carboxy and hydroxy groups (105)
and completed the total synthesis of daphlongamine H (2).
Our synthetic route gave rise to daphlongamine H (2) in 20
steps from imine 77 (longest linear sequence) and constitutes
the first total synthesis of this calyciphylline B-type alkaloid.
Structural Revision. By virtue of our synthetic route,
which provided sufficient amounts of materials for follow-up
characterization studies, and following interpretation of 2D
NMR data (900 MHz spectrometer) of synthetic daphlong-
amine H (2), we were confident in our assignment of the R-C6
stereochemistry. However, we were initially surprised to find
Scheme 16. Synthesis of Isodaphlongamine H (3) and
Daphlongamine H (2)a
aReagents and conditions: (a) NaCNBH3, BF3·Et2O, THF, 23 to 66
°C; (b) CrO3, H2SO4, H2O, acetone, 0 °C (68%, 2 steps); (c) TFAA,
CH2Cl2, −78 °C, then SOCl2, −78 to 0 °C (71%); (d) aq. H2O2,
TFAA, CH2Cl2, 0 to 23 °C (35%); (e) LiAlH4, THF, −78 to 66 °C;
(f) NaCNBH3, BF3·Et2O, THF, 23 to 66 °C; (g) CrO3, H2SO4, H2O,
acetone, 0 °C; (h) cyanuric chloride, NEt3, MeCN, 23 °C (13%, 4
steps).
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that our NMR spectra were in good agreement with those
reported for (S-C6 configured) deoxyisocalyciphylline B
(Figure 2a).14 Eventually, careful analysis of the reported 2D
NOESY spectrum of deoxyisocalyciphylline B revealed that the
S-C6 stereochemistry had been misassigned,29 and we
established that isolated deoxyisocalyciphylline B (revised
structure: 2′) and daphlongamine H (2) are the same natural
product. Furthermore, we concluded that the spectroscopic
data reported for daphlongamine H (2) corresponds to its
likely ammonium salt. Thus, NMR experiments of our
synthetic daphlongamine H (2) using old CDCl3 (putatively
containing residual acid) led to spectra which were in
agreement with the values reported for naturally occurring 2.
Our structural revision of deoxyisocalyciphylline B raises
concern regarding the reported structures of the related
calyciphylline B-type alkaloids oldhamiphylline A (4),16a
daphnioldhanine J (5),16b and caldaphnidine R (6)17b that
were reported to also feature an S-C6 configuration (Figure
2b). The structures of these latter three natural products were
to some extent established by analogy to (previously reported
and misassigned) deoxyisocalyciphylline B, and thus a similar
revision of the C6 stereochemistry might be required for these
cases as well.
The pertinent NMR spectra (NOESY) enabling us to verify
the C6 configurations of oldhamiphylline A (4), daphnioldha-
nine J (5), and caldaphnidine R (6) were not included in the
isolation papers.16,17 However, comparison of the 13C{1H}
NMR shifts of C6 reported for 4 (δCD3OD: 44.6 ppm) and 5
(δCDCl3: 42.6 ppm) with S-C6 configured deoxycalyciphylline B
(1) (δCDCl3: 47.8 ppm) and R-C6 configured daphlongamine H
(2) (δCDCl3: 40.8 ppm; δCD3OD: 42.9 ppm) indicates that the
reported values are more in line with an R-C6 configuration,
suggesting that 4 and 5 likely have been misassigned. Because
the methanolysis product 6 was structurally elucidated by
NMR data comparison with (previously isolated and
misassigned) deoxyisocalyciphylline B, its C6 configuration in
all probability also was misassigned. At this stage, the suspected
occurrence of the calyciphylline B-type alkaloids as a
diastereomeric C5/C6 quartet that result biosynthetically
from a nonselective hydroacyloxylation remains highly
speculative.14,18 Because only the natural existence of
deoxycalyciphylline B (1) and daphlongamine H (2) is
unambiguously confirmed to date (by X-ray analysis and
total synthesis, respectively), it may rather be that the
appended propionic acid side chain undergoes hydroacylox-
ylation onto the tetrasubstituted olefin from either the α- or β-
face via intramolecular proton transfer (Figure S11),29 thus
only resulting in calyciphylline B-type alkaloids with
corresponding C5/C6 configurations as found in 1 and 2.
■ CONCLUSIONS
We have reported the evolution of strategies toward the total
synthesis of calyciphylline B-type natural products, a subfamily
of the polycyclic Daphniphyllum alkaloids. Our initial efforts to
construct the central piperidine ring via 6π-azaelectrocycliza-
tion revealed a wealth of interesting reactivity surrounding
oxazaborinine heterocycles, which were ultimately unsuccessful
as intermediates in the total synthesis effort. A different
strategy encompassing an intramolecular Heck−Suzuki cou-
pling cascade and diastereoselective hydrogenation highlighted
synthetic challenges in forming the western all-cis methine
substructure of the calyciphylline B-type alkaloids and
eventually inspired a successful approach. Therein, a key
complexity-building Mannich reaction was developed in the
opening step. Elaboration of the resulting β-amino lactone gave
access to a highly functionalized acyclic precursor which
underwent carefully orchestrated and efficient cyclizations to
forge the fused, hexacyclic framework of the natural products
in a diastereoselective manner. Our synthetic studies
culminated in the first total synthesis of daphlongamine H
(2), gave access to isodaphlongamine H (3), and also led to
revision of the reported structure of deoxyisocalyciphylline B.
■ EXPERIMENTAL SECTION
General information: Unless otherwise noted, all reactions were
performed in flame or oven-dried glassware fitted with rubber septa
under a positive pressure of nitrogen using standard Schlenk
techniques. Air- and moisture-sensitive liquids were transferred via a
syringe or stainless steel cannula through rubber septa. Solids were
added under inert gas or were dissolved in appropriate solvents and
added using a needle and syringe. Low-temperature reactions were
carried out in a Dewar vessel filled with a cooling agent: acetone/dry
ice (−78 °C), H2O/ice (0 °C). Reaction temperatures above 23 °C
were conducted in an oil bath or in a heated metal block (reactions
conducted in vials). The reactions were magnetically stirred and
monitored by NMR spectroscopy or analytical thin-layer chromatog-
raphy (TLC) using glass plates precoated with silica gel (Silicycle
Siliaplates, glass backed, extra hard layer, 60 Å, 250 μm thickness,
F254 indicator). TLC plates were visualized by exposure to ultraviolet
light (254 nm), were stained by submersion in aqueous potassium
permanganate solution (KMnO4) or ceric ammonium molybdate
solution, and were developed by heating with a heat gun. Flash-
column chromatography on silica gel was performed as described by
Figure 2. (A) 13C{1H} NMR spectra comparison of synthetic
daphlongamine H (2) and deoxyisocalyciphylline B (reported
structure). (B) Related calyciphylline B-type alkaloids with reported
S-C6 configuration that were structurally assigned by analogy to
(misassigned) deoxyisocalyciphylline B.
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Still et al.,65 employing silica gel (Silicycle silica gel, 40−63 μm
particle size). Organic solutions were concentrated under reduced
pressure on a Heidolph temperature-controlled rotary evaporator
equipped with a dry ice/isopropanol condenser. All yields refer to
chromatographically and spectroscopically (1H and 13C{1H} NMR)
pure material. Materials: Unless noted below, commercial reagents
were purchased from MilliporeSigma, Acros Organics, Chem-Impex,
Oakwood Chemical, Combi-blocks, TCI, and/or Alfa Aesar and used
without additional purification. Solvents were purchased from Fisher
Scientific, Acros Organics, Alfa Aesar, and Sigma-Aldrich. THF,
diethyl ether (Et2O), acetonitrile (MeCN), benzene (PhH), toluene
(PhMe), methanol (MeOH), and triethylamine (Et3N) were sparged
with argon and dried by passing through alumina columns using argon
in a Glass Contour solvent purification system. Dichloromethane
(CH2Cl2, DCM) and diisopropylamine (DIPA) were freshly distilled
over calcium hydride under a N2 atmosphere prior to use. NMR
spectroscopy: NMR spectral data were obtained using deuterated
solvents, obtained from Cambridge Isotope Laboratories, Inc. 1H
NMR and 13C{1H} NMR data were recorded on Bruker
spectrometers operating at 400, 500, 600, 700, or 900 MHz for
proton nuclei (and 100, 125, 150, 175, or 225 MHz for carbon
nuclei). Proton chemical shifts are expressed in parts per million
(ppm, δ scale) and are referenced to residual protium in the NMR
solvent (CHCl3: δ 7.26, C6HD5: δ 7.16, CHD2OD: δ 3.31). Carbon
chemical shifts are expressed in parts per million (δ scale, assigned
carbon atom) and are referenced to the carbon resonance of the NMR
solvent (CDCl3: δ 77.16, C6D6: δ 128.06, CD3OD: δ 47.67).
19F
NMR spectra were acquired on a Bruker AVQ-400 spectrometer and
internally referenced to CFCl3 (δ 0.00).
11B NMR spectra were
acquired on an AVB-400 or AV-600 spectrometer, and chemical shifts
were referenced to an external reference BF3·OEt2 (δ 0.00). When
13C
signals appeared too weak and/or broad, HMBC and HSQC spectra
were acquired to confirm signal authenticity. 1H NMR spectroscopic
data are reported as follows: Chemical shift in ppm (multiplicity,
coupling constants J (Hz), integration) (e.g., “5.21 (t, 3J = 7.3 Hz,
1H)”). The multiplicities are abbreviated with s (singlet), br s (broad
singlet), d (doublet), t (triplet), q (quartet), p (pentet), se (sextet), h
(heptet), m (multiplet), and app (apparent multiplicity). In the case
of combined multiplicities, the multiplicity with the larger coupling
constant is stated first. Except for multiplets, the chemical shift of all
signals, as well for centrosymmetric multiplets, is reported as the
center of the resonance range. Data for 13C, 19F, and 11B NMR
spectroscopy are reported in terms of chemical shift (δ ppm). In
addition to 1D NMR experiments, 2D NMR techniques such as
homonuclear correlation spectroscopy (COSY), heteronuclear single
quantum coherence (HSQC), heteronuclear multiple bond coherence
(HMBC), and nuclear Overhauser enhancement spectroscopy
(NOESY) were used to assist structure elucidation. All raw FID
files were processed, and the spectra were analyzed using the program
MestReNOVA 11.0 from Mestrelab Research S. L. The AVB-400,
AVQ-400, AV-500, DRX-500, and AV-600 instruments were partially
supported by NIH grants SRR023679A, RR02424A-01, S10RR03353-
01, and 1S10RR016634-01, and NSF grants CHE-9633007, CHE-
8208992, CHE-0130862, and CHE-8703048. The AV-700 instrument
was supported by the Berkeley College of Chemistry NMR facility.
Funds for the QB3 900 MHz NMR spectrometer were provided by
the NIH through grant GM68933. Mass spectrometry: High-
resolution mass spectra (HRMS) were obtained from the Mass
Spectral Facility at the University of California, Berkeley, on a
PerkinElmer AxION 2 UHPLC-TOF Instrument (ESI) or a Waters
AutoSpec Premier mass spectrometer (EI). Data acquisition and
processing were performed using the XcaliburTM software. IR
spectroscopy: IR spectroscopic data were recorded on a Bruker
ALPHA FT-IR spectrophotometer using a diamond attenuated total
reflectance (ATR) accessory. If required, substances were dissolved in
dichloromethane prior to direct application on the ATR unit. Data are
represented as follows: frequency of absorption (cm−1) and intensity
of absorption (s = strong, m = medium, w = weak, br = broad). HPLC
analyses. Analytical HPLC on the chiral stationary phase was
performed on a computer-operated PerkinElmer system (Flexar
HPLC system). Column, oven temperature, solvent system, flow rate,
detection mode, and retention times are given in the relevant section
of the experimental part. Optical rotations: Optical rotations were
acquired on a PerkinElmer 241 Polarimeter. Melting points: Melting
points were measured on a Laboratory Devices Mel-Temp II.
Experimental Details. Compounds 2, 3, 41−43, and 80−103
(synthetic procedures, characterization data, NMR spectra, and X-ray
structures), as well as the natural product NMR spectra comparison,
and discussion of the structural revision have been previously reported
by us20,34 and are not reproduced here.
Synthesis of (4R,5S)-5-Methyl-4-((triisopropylsilyl)ethynyl)-
tetrahydro-2H-pyran-2-one (25). According to Hayashi’s method,24
a flask was charged with propargyl alcohol 24 (6.33 g, 17.4 mmol, 1.1
equiv), [RhCl(cod)]2 (194 mg, 0.40 mmol, 2.5 mol %), and Cs2CO3
(515 mg, 1.58 mmol, 0.1 equiv). A solution of known α,β-unsaturated
lactone 2323 (1.77 g, 15.8 mmol, 1.0 equiv) in N2-sparged (1 h)
toluene (45 mL) was then added, and the resulting orange mixture
was heated to 80 °C. After 36 h, the mixture was cooled to 23 °C and
filtered through a pad of Celite, eluting with ethyl acetate (200 mL).
The filtrate was concentrated, and the crude residue was purified by
flash column chromatography (10% ethyl acetate in hexanes) to give
lactone 25 (2.36 g, 8.02 mmol, 51%) as a yellow oil. TLC (20% ethyl
acetate in hexanes): Rf = 0.33 (KMnO4).
1H NMR (700 MHz,
CDCl3): δ 4.38 (dd, J = 11.5, 4.4 Hz, 1H), 3.92−3.86 (m, 1H), 2.99−
2.90 (m, 1H), 2.64−2.54 (m, 2H), 2.09−2.00 (m, 1H), 1.14 (d, J =
6.7 Hz, 3H), 1.10−1.00 (m, 21H). 13C{1H} NMR (176 MHz,
CDCl3): δ 169.1, 107.3, 84.1, 73.7, 35.8, 34.1, 32.5, 18.6, 14.9, 11.1.
IR (Diamond-ATR, neat) ν ̃max: 2941 (m), 2863 (s), 1737 (s), 1215
(s), 1048 (s), 882 (s), 675 (s). HRMS (ESI): calcd for ([M + Na]
C17H30NaO2Si)
+, 317.1907; found, 317.1907. [α]D
20 = −25.0° (c = 2.2,
CH2Cl2).
Synthesis of (2S,3R)-3-(2-(Methoxy(methyl)amino)-2-oxoethyl)-
2-methyl-5-(triisopropylsilyl)pent-4-yn-1-yl methanesulfonate (26).
A solution of lactone 25 (960 mg, 3.26 mmol, 1.0 equiv) in THF (20
mL) was treated sequentially with N,O-dimethylhydroxylamine
hydrochloride (477 mg, 4.89 mmol, 1.5 equiv) and isopropylmagne-
sium chloride solution (2 M in THF, 4.89 mL, 9.78 mmol, 3.0 equiv)
at 0 °C. After 20 min, the mixture was diluted with saturated aqueous
ammonium chloride solution (50 mL) and dichloromethane (50 mL).
The layers were separated, the aqueous layer was extracted with
dichloromethane (3 × 40 mL), and the combined organic extracts
were washed with saturated aqueous sodium chloride solution (100
mL). The washed organic layer was dried over sodium sulfate. The
dried solution was filtered, and the filtrate was concentrated in vacuo.
The residue was used in the next step without further purification. A
solution of the crude alcohol (assuming 3.26 mmol) in dichloro-
methane (20 mL) was treated sequentially with triethylamine (1.36
mL, 9.78 mmol, 3.0 equiv) and methanesulfonyl chloride (378 μL,
4.89 mmol, 1.5 equiv) at 0 °C. After 15 min, the mixture was diluted
with saturated aqueous sodium bicarbonate solution (20 mL). The
layers were separated, the aqueous layer was extracted with
dichloromethane (3 × 20 mL), and the combined organic extracts
were washed with saturated aqueous sodium chloride solution (30
mL). The washed organic layer was dried over magnesium sulfate.
The dried solution was filtered, and the filtrate was concentrated in
vacuo. The crude residue was purified by flash column chromatog-
raphy (40% → 50% ethyl acetate in hexanes) to give Weinreb amide
26 (1.08 g, 2.49 mmol, 76% over 2 steps) as a white solid. TLC (50%
ethyl acetate in hexanes): Rf = 0.32 (KMnO4).
1H NMR (700 MHz,
CDCl3): δ 4.22−4.13 (m, 2H), 3.69 (s, 3H), 3.36−3.30 (m, 1H), 3.17
(s, 3H), 3.13 (s, 1H), 3.02 (s, 3H), 2.79 (dd, J = 15.8, 7.6 Hz, 1H),
2.51 (dd, J = 15.8, 7.1 Hz, 1H), 2.14−2.06 (m, 1H), 1.08−0.97 (m,
24H). 13C{1H} NMR (176 MHz, CDCl3): δ 171.5, 106.8, 84.4, 72.9,
61.5, 37.5, 35.4, 35.1 (br), 32.3 (br), 31.7, 30.2, 18.7, 11.6, 11.3. IR
(Diamond-ATR, neat) νm̃ax: 2940 (m), 2864 (m), 1659 (s), 1462
(m), 1355 (s), 1174 (s), 961 (s), 883 (s), 835 (s), 677 (s). HRMS
(ESI): calcd for ([M + H] C20H40NO5SSi)
+, 434.2391; found,
434.2399. [α]D
20 = −46.9° (c = 1.0, CH2Cl2). mp 40−45 °C.
Synthesis of (2S,3R)-3-(2-Hydroxyethyl)-2-methyl-5-
(triisopropylsilyl)pent-4-yn-1-yl Methanesulfonate (27). A solution
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of Weinreb amide 26 (1.00 g, 2.31 mmol, 1.0 equiv) in THF (15 mL)
was treated with lithium aluminium hydride (70.0 mg, 1.84 mmol, 0.8
equiv) at 0 °C. After 15 min, the mixture was diluted with diethyl
ether (40 mL), water (280 μL), and aqueous sodium hydroxide
solution (15 wt %, 70.0 μL). The mixture was warmed to 23 °C and
stirred vigorously. After 15 min, magnesium sulfate was added and
stirring was continued. After further 15 min, the mixture was filtered
through a pad of Celite, eluting with diethyl ether (100 mL), and the
filtrate was concentrated in vacuo. The residue was used in the next
step without further purification. A solution of the crude aldehyde
(assuming 2.31 mmol) in dichloromethane (15 mL) and methanol (3
mL) was treated with sodium borohydride (87.0 mg, 2.31 mmol, 1.0
equiv) at 0 °C. After 15 min, the mixture was diluted with saturated
aqueous sodium bicarbonate solution (20 mL). The layers were
separated, the aqueous layer was extracted with dichloromethane (3 ×
20 mL), and the combined organic extracts were washed with
saturated aqueous sodium chloride solution (30 mL). The washed
organic layer was dried over magnesium sulfate. The dried solution
was filtered, and the filtrate was concentrated in vacuo. The crude
residue was purified by flash column chromatography (30% → 50%
ethyl acetate in hexanes) to give alcohol 27 (773 mg, 2.05 mmol, 89%
over 2 steps) as a white solid. TLC (50% ethyl acetate in hexanes): Rf
= 0.22 (KMnO4).
1H NMR (700 MHz, CDCl3): δ 4.22−4.12 (m,
2H), 3.88−3.77 (m, 2H), 3.01 (s, 3H), 2.90 (dt, J = 10.7, 4.2 Hz,
1H), 2.05−1.98 (m, 1H), 1.84 (s, 1H), 1.82−1.75 (m, 1H), 1.69−
1.61 (m, 1H), 1.09−0.97 (m, 24H). 13C{1H} NMR (176 MHz,
CDCl3): δ 107.3, 84.9, 73.0, 61.2, 37.3, 36.4, 35.8, 30.8, 18.74, 18.73,
11.6, 11.3. IR (Diamond-ATR, neat) ν ̃max: 3640 (br), 3379 (br), 2940
(s), 2864 (s), 1462 (m), 1354 (s), 1174 (s), 960 (s), 882 (m), 837
(m), 668 (s). HRMS (ESI): calcd for ([M + Na] C18H36NaO4SSi)
+,
399.1996; found, 399.1971. [α]D
20 = −19.9° (c = 1.0, CH2Cl2). mp
50−55 °C.
Synthesis of (2S,3R)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-
Methylpent-4-yn-1-yl Methanesulfonate (28). A solution of alcohol
27 (690 mg, 1.83 mmol, 1.0 equiv) in THF (10 mL) was treated with
tetrabutylammonium fluoride (TBAF) solution (1 M in THF, 3.67
mL, 3.67 mmol, 2.0 equiv) at 0 °C. After 1 h, the mixture was diluted
with saturated aqueous sodium bicarbonate solution (20 mL). The
layers were separated, the aqueous layer was extracted with ethyl
acetate (3 × 20 mL), and the combined organic extracts were washed
with saturated aqueous sodium chloride solution (30 mL). The
washed organic layer was dried over magnesium sulfate. The dried
solution was filtered, and the filtrate was concentrated in vacuo. The
residue was used in the next step without further purification. A
solution of the crude alkyne (assuming 1.83 mmol) in dichloro-
methane (15 mL) was treated sequentially with imidazole (378 mg,
5.49 mmol, 3.0 equiv) and tert-butyldimethylsilyl chloride (414 mg,
2.75 mmol, 1.5 equiv) at 0 °C. After 20 min, the mixture was diluted
with saturated aqueous sodium bicarbonate solution (20 mL). The
layers were separated, the aqueous layer was extracted with diethyl
ether (3 × 20 mL), and the combined organic extracts were washed
with saturated aqueous sodium chloride solution (30 mL). The
washed organic layer was dried over magnesium sulfate. The dried
solution was filtered, and the filtrate was concentrated in vacuo. The
crude residue was purified by flash column chromatography (10% →
20% ethyl acetate in hexanes) to give silyl ether 28 (605 mg, 1.81
mmol, 99% over 2 steps) as a colorless liquid. TLC (30% ethyl acetate
in hexanes): Rf = 0.39 (KMnO4).
1H NMR (700 MHz, CDCl3): δ
4.18 (dd, J = 9.8, 8.3 Hz, 1H), 4.13 (dd, J = 9.7, 6.1 Hz, 1H), 3.78−
3.70 (m, 2H), 3.00 (s, 3H), 2.87−2.83 (m, 1H), 2.07 (d, J = 2.5 Hz,
1H), 2.05−1.98 (m, 1H), 1.74−1.67 (m, 1H), 1.65−1.58 (m, 1H),
0.99 (d, J = 6.9 Hz, 3H), 0.88 (s, 9H), 0.05 (s, 3H), 0.05 (s, 3H).
13C{1H} NMR (176 MHz, CDCl3): δ 83.3, 72.8, 71.9, 60.7, 37.3,
35.9, 35.6, 29.1, 26.0, 18.4, 11.5, −5.2, −5.3. IR (Diamond-ATR,
neat) νm̃ax: 3284 (w), 2929 (m), 2856 (m), 1471 (m), 1356 (s), 1175
(s), 1101 (s), 960 (s), 829 (s), 775 (s), 637 (m). HRMS (ESI): calcd
for ([M + Na] C15H30NaO4SSi)
+, 357.1526; found, 357.1540. [α]D
20 =
+1.2° (c = 1.0, CH2Cl2).
Synthesis of N-Allyl-N-((2S,3R)-3-(2-((tert-butyldimethylsilyl)-
oxy)ethyl)-2-methylpent-4-yn-1-yl)-2,2,2-trifluoroacetamide (29).
A solution of silyl ether 28 (1.90 g, 5.69 mmol, 1.0 equiv) in
acetonitrile (5.5 mL) was treated with triethylamine (950 μL, 6.82
mmol, 1.2 equiv), allylamine (6.40 mL, 85.3 mmol, 15 equiv), and
sodium iodide (1.28 g, 8.53 mmol, 1.5 equiv) at 23 °C. The resulting
mixture was heated to 45 °C. After 72 h, the mixture was cooled to 23
°C and then was filtered through a pad of Celite, eluting with ethyl
acetate (100 mL). The filtrate was concentrated in vacuo, and the
residue was used in the next step without further purification. A
solution of the crude secondary amine (assuming 5.69 mmol) in
dichloromethane (60 mL) was treated sequentially with triethylamine
(2.37 mL, 17.1 mmol, 3.0 equiv) and trifluoroacetic anhydride (950
μL, 6.83 mmol, 1.2 equiv) at −78 °C. After 15 min, the mixture was
diluted with saturated aqueous sodium bicarbonate solution (50 mL)
and warmed to 23 °C. The layers were separated, the aqueous layer
was extracted with diethyl ether (3 × 30 mL), and the combined
organic extracts were washed with saturated aqueous sodium chloride
solution (50 mL). The washed organic layer was dried over
magnesium sulfate. The dried solution was filtered, and the filtrate
was concentrated in vacuo. The crude residue was purified by flash
column chromatography (10% → 20% ethyl acetate in hexanes) to
give amide 29 (1.76 g, 4.50 mmol, 79% over 2 steps) as a red oil. TLC
(10% ethyl acetate in hexanes): Rf = 0.39 (UV/KMnO4). Note: As
determined by NMR spectroscopy, amide 29 exists as a mixture of
rotamers (3:1 ratio) at 23 °C. In cases where the proton or carbon
atoms show a double set of signals, the signal of the minor rotamer is
marked with an asterisk. 1H NMR (700 MHz, CDCl3): δ 5.81−5.68
(m, 1H), 5.30−5.19 (m, 2H), 4.28* (dd, J = 15.1, 5.5 Hz, 1H), 4.16
(dd, J = 16.6, 4.8 Hz, 1H), 4.00 (dd, J = 16.6, 6.6 Hz, 1H), 3.87* (dd,
J = 15.1, 6.7 Hz, 1H), 3.79−3.68 (m, 2H), 3.51 (dd, J = 13.4, 6.5 Hz,
1H), 3.36* (dd, J = 14.7, 6.6 Hz, 1H), 3.22 (dd, J = 13.6, 8.5 Hz, 1H),
2.71−2.62 (m, 1H), 2.16−2.08 (m, 2H), 2.00−1.93* (m, 1H), 1.75−
1.65 (m, 1H), 1.63−1.55 (m, 1H), 0.97−0.91 (m, 3H), 0.91−0.84
(m, 9H), 0.06−0.03 (m, 6H). 13C{1H} NMR (176 MHz, CDCl3): δ
157.4 (q, J = 35.5 Hz) 132.2, 131.2*, 119.2, 118.8*, 116.6 (q, J =
287.9 Hz), 84.1, 83.4*, 72.1*, 71.9, 60.7, 60.6*, 51.5, 51.3 (br), 49.6,
36.1*, 36.0, 35.1*, 34.1, 30.5*, 30.0, 26.0*, 26.0, 18.4*, 18.4, 12.9*,
12.3, −5.2, −5.3. 19F NMR (376 MHz, CDCl3): δ −67.05*, −68.16.
IR (Diamond-ATR, neat) νm̃ax: 3310 (w), 2953 (m), 2929 (m), 2857
(m), 1690 (s), 1204 (s), 1170 (s), 1141 (s), 1098 (s), 830 (s), 811
(m), 775 (s) . HRMS (ESI): ca lcd for ([M + Na]
C19H32F3NNaO2Si)
+, 414.2047; found, 414.2048. [α]D
20 = −26.5° (c
= 1.0, CH2Cl2).
Synthesis of (R)-1,2,3,6,7,7a-Hexahydro-5H-inden-5-one (31).
Lithium metal (1.25 g, 180 mmol, 4.5 equiv) was added portionwise
to freshly condensed ammonia (250 mL) at −78 °C, whereupon the
mixture turned deep blue. After 30 min, a solution of 5-methoxyindan
(22) (5.92 g, 40.0 mmol, 1.0 equiv) in THF (30 mL) was added
dropwise at −78 °C. The mixture was then slowly warmed to −40 °C
over a period of 3 h, whereupon ethanol (30 mL) was added, after
which the blue color faded. The cooling bath was then removed, and
the ammonia was allowed to evaporate overnight. The resulting
residue was partitioned between water (200 mL) and diethyl ether
(100 mL). The layers were separated, the aqueous layer was extracted
with diethyl ether (4 × 50 mL), and the combined organic extracts
were washed with saturated aqueous sodium chloride solution (2 ×
40 mL). The washed solution was dried over magnesium sulfate, the
dried solution was filtered, and the filtrate was concentrated in vacuo.
The crude enol ether (6.25 g yellow oil, ≥99%) was used in the next
step without further purification. A portion of the crude enol ether
(4.50 g, 30.0 mmol, 1.0 equiv) in methanol (80 mL) and water (40
mL) was treated with oxalic acid (6.78 g, 75.0 mmol, 2.5 equiv) at 0
°C. After 20 min, the mixture was diluted with saturated aqueous
sodium bicarbonate solution (200 mL) and diethyl ether (70 mL).
The layers were separated, the aqueous layer was extracted with
diethyl ether (3 × 50 mL), and the combined organic extracts were
washed with saturated aqueous sodium chloride solution (2 × 50
mL). The washed solution was dried over magnesium sulfate, the
dried solution was filtered, and the filtrate was concentrated in vacuo.
The crude ketone 30 was used in the next step without further
purification. Based on a slight modification of Deng’s method,26 a
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solution of the crude ketone 30 (assuming 30.0 mmol) in chloroform
(60 mL) was treated with cinchona alkaloid catalyst QD (2.17 g, 4.50
mmol, 15 mol %) and (R)-2-chloropropionic acid (977 mg, 9.00
mmol, 30 mol %) at −20 °C. After stirring for 10 days at this
temperature, the mixture was directly purified by flash column
chromatography (40%→ 60% diethyl ether in pentane) to give enone
31 (2.04 g, 15.0 mmol, 50% over 2 steps, 57% ee) as a yellow oil. TLC
(10% diethyl ether in pentane): Rf = 0.31 (UV/KMnO4).
1H NMR
(700 MHz, CDCl3): δ 5.86 (d, J = 2.3 Hz, 1H), 2.65−2.55 (m, 1H),
2.55−2.48 (m, 1H), 2.48−2.37 (m, 2H), 2.31−2.23 (m, 1H), 2.23−
2.16 (m, 1H), 2.09−2.02 (m, 1H), 1.91−1.83 (m, 1H), 1.72−1.63
(m, 1H), 1.62−1.53 (m, 1H), 1.21 (qd, J = 11.9, 7.2 Hz, 1H).
13C{1H} NMR (176 MHz, CDCl3): δ 199.9, 175.6, 122.3, 43.2, 37.5,
32.9, 31.9, 29.3, 23.9. IR (Diamond-ATR, neat) νm̃ax: 2947 (m), 2862
(m), 1657 (s), 1318 (m), 1240 (m), 1213 (m), 1183 (m), 867 (s).
HRMS (ESI): calcd for ([M + H] C9H13O)
+, 137.0961; found,
137.0968. [α]D
20 = +0.1° (c = 1.0, CH2Cl2).
Synthesis of (R)-2,6,7,7a-Tetrahydro-1H-inden-5-yl Trifluorome-
thanesulfonate (32). A solution of enone 31 (57% ee, 690 mg, 5.07
mmol, 1.0 equiv) in THF (30 mL) was treated with potassium
bis(trimethylsilyl)amide solution (0.7 M in PhMe, 6.12 mL, 4.31
mmol, 0.85 equiv) at −15 °C. The resulting dark orange mixture was
then warmed to 23 °C. After 30 min, the mixture was cooled to 0 °C,
whereupon N-phenyl-bis(trifluoromethanesulfonimide) (2.17 g, 6.08
mmol, 1.2 equiv) was added in one portion. After 5 min, the mixture
was diluted with saturated aqueous sodium bicarbonate solution (50
mL). The layers were separated, the aqueous layer was extracted with
diethyl ether (3 × 30 mL), and the combined organic extracts were
washed with saturated aqueous sodium chloride solution (50 mL).
The washed organic layer was dried over magnesium sulfate. The
dried solution was filtered, and the filtrate was concentrated in vacuo.
The crude residue was purified by flash column chromatography
(100% hexanes) to give triflate 32 (1.16 g, 4.31 mmol, 85%) as a
colorless oil. TLC (100% hexanes): Rf = 0.36 (UV/KMnO4).
1H
NMR (700 MHz, CDCl3): δ 6.30 (d, J = 2.5 Hz, 1H), 5.71 (d, J = 2.9
Hz, 1H), 2.70−2.59 (m, 2H), 2.45−2.36 (m, 3H), 2.20−2.13 (m,
1H), 2.13−2.06 (m, 1H), 1.49−1.42 (m, 1H), 1.42−1.34 (m, 1H).
13C{1H} NMR (176 MHz, CDCl3): δ 151.6, 139.3, 129.1, 118.7 (q, J
= 380.9 Hz), 115.7, 42.4, 33.1, 31.0, 29.1, 29.0. 19F NMR (376 MHz,
CDCl3): δ −73.04. IR (Diamond-ATR, neat) νm̃ax: 2931 (w), 2844
(w), 1416 (s), 1246 (m), 1201 (s), 1138 (s), 1043 (s), 1027 (s), 888
(m), 860 (s). HRMS (EI): calcd for ([M], C10H11F3O3S)
+: 268.0376;
found, 268.0383. [α]D
20 = +10.6° (c = 2.2, CH2Cl2).
Synthesis of (R)-2,6,7,7a-Tetrahydro-1H-indene-5-carboxylic
Acid (33). A solution of triflate 32 (1.16 g, 4.31 mmol, 1.0 equiv)
in N,N-dimethylformamide (20 mL) was treated with pyridine (730
μL, 9.05 mmol, 2.1 equiv), tetrabutylammonium chloride (1.32 g,
4.74 mmol, 1.1 equiv), and palladium(II) acetate (96.8 mg, 0.43
mmol, 0.1 equiv) at 23 °C. The reaction mixture was sparged with
carbon monoxide gas for 15 min, and stirring was then continued
under 1 atm carbon monoxide pressure (balloon) at 60 °C. After 16 h,
the mixture was cooled to 23 °C and was diluted with saturated
aqueous ammonium chloride solution (70 mL). The layers were
separated, the aqueous layer was extracted with ethyl acetate (4 × 40
mL), and the combined organic extracts were washed with saturated
aqueous sodium chloride solution (50 mL). The washed organic layer
was dried over magnesium sulfate. The dried solution was filtered, and
the filtrate was concentrated in vacuo. The crude residue was purified
by flash column chromatography (40% ethyl acetate in hexanes) to
give carboxylic acid 33 (531 mg, 3.23 mmol, 75%, 53% ee) as a white
solid. TLC (40% ethyl acetate in hexanes): Rf = 0.44 (UV/KMnO4).
1H NMR (700 MHz, CDCl3): δ 7.44 (d, J = 2.6 Hz, 1H), 5.97 (d, J =
2.8 Hz, 1H), 2.68−2.58 (m, 2H), 2.48−2.40 (m, 2H), 2.35−2.26 (m,
1H), 2.24−2.16 (m, 1H), 2.13−2.08 (m, 1H), 1.46−1.38 (m, 1H),
1.25 (qd, J = 12.5, 4.9 Hz, 1H). 13C{1H} NMR (176 MHz, CDCl3): δ
173.6, 142.7, 134.5, 133.7, 129.8, 42.8, 32.8, 31.8, 29.4, 25.3. IR
(Diamond-ATR, neat) νm̃ax: 3275 (br), 3073 (m), 1656 (s), 1376 (s),
1206 (s), 1141 (s), 602 (s). HRMS (ESI): calcd for ([M − H]
C10H11O2)
−, 163.0765; found, 163.0762. [α]D
20 = +75.2° (c = 1.1,
CH2Cl2). mp 180−185 °C.
Synthesis of (E)-2-((3S,4S)-1-Allyl-3-(2-((tert-butyldimethylsilyl)-
oxy)ethyl)-4-methylpyrrolidin-2-ylidene)-1-((R)-2,6,7,7a-tetrahy-
dro-1H-inden-5-yl)ethan-1-one (36). A mixture of carboxylic acid 33
(53% ee, 460 mg, 2.80 mmol, 1.2 equiv) in dichloromethane (23 mL)
and N,N-dimethylformamide (4 drops) was treated dropwise with
oxalyl chloride (280 μL, 3.27 mmol, 1.4 equiv) at 0 °C. The resulting
mixture was warmed to 23 °C, whereupon it turned into a clear,
orange solution. After 2 h, the mixture was concentrated in vacuo to
give acid chloride 34 which was used in the next step without further
purification. A flask was charged with acid chloride 34 (assuming 2.80
mmol), bis(triphenylphosphine)palladium(II) dichloride (81.8 mg,
0.12 mmol, 5 mol %), and copper(I) iodide (44.4 mg, 0.23 mmol, 10
mol %). A solution of amide 29 (911 mg, 2.33 mmol, 1.0 equiv) in
triethylamine (20 mL) was then added at 23 °C. After 30 min, the
mixture was diluted with water (40 mL) and diethyl ether (30 mL).
The layers were separated, the aqueous layer was extracted with
diethyl ether (3 × 20 mL), and the combined organic extracts were
washed with saturated aqueous sodium chloride solution (30 mL).
The washed organic layer was dried over magnesium sulfate. The
dried solution was filtered, and the filtrate was concentrated in vacuo.
The crude residue was used in the next step without further
purification. The crude alkynone (assuming 2.80 mmol) in methanol
(17 mL), THF (5 mL) and water (5 mL) was treated with potassium
carbonate (966 mg, 6.99 mmol, 3.0 equiv) at 0 °C. The resulting
mixture was then warmed to 23 °C. After 18 h, the mixture was
diluted with saturated aqueous sodium bicarbonate solution (50 mL).
The layers were separated, the aqueous layer was extracted with ethyl
acetate (4 × 40 mL), and the combined organic extracts were washed
with saturated aqueous sodium chloride solution (50 mL). The
washed organic layer was dried over magnesium sulfate. The dried
solution was filtered, and the filtrate was concentrated in vacuo. The
crude residue was purified by flash column chromatography (10% →
20% ethyl acetate in hexanes) to give vinylogous amide 36 (701 mg,
1.59 mmol, 68% over three steps, ∼3:1 d.r. at C10) as an orange oil.
TLC (15% ethyl acetate in hexanes): Rf = 0.36 (UV/KMnO4). Note:
As a result of the low enantiomeric purity of carboxylic acid 33 (53%
ee), vinylogous amide 36 was obtained as an inseparable mixture of
diastereomers (∼3:1 d.r. at C10). In cases where the proton or carbon
atoms show a double set of signals, the signal of the minor
diastereomer is marked with an asterisk. 1H NMR (700 MHz,
CDCl3): δ 6.99 (s, 1H), 6.98* (s, 1H), 5.79−5.72 (m, 2H), 5.43* (s,
1H), 5.42 (s, 1H), 5.26−5.15 (m, 2H), 3.90−3.78 (m, 4H), 3.76−
3.70 (m, 1H), 3.58−3.51 (m, 1H), 2.88 (d, J = 10.3 Hz, 1H), 2.74*
(dd, J = 17.9, 4.7 Hz, 1H), 2.68−2.56 (m, 2H), 2.48−2.31 (m, 4H),
2.19−2.12 (m, 1H), 2.11−2.05 (m, 1H), 1.89−1.83 (m, 1H), 1.61−
1.54 (m, 2H), 1.43−1.34 (m, 1H), 1.25−1.18 (m, 1H), 0.98 (d, J =
7.1 Hz, 3H), 0.88 (s, 9H), 0.06 (s, 3H), 0.04 (s, 3H). 13C{1H} NMR
(176 MHz, CDCl3): δ 188.59, 188.56*, 169.3, 169.2*, 144.0*, 143.9,
142.9*, 142.8, 130.9*, 130.8, 128.6, 128.5*, 125.5, 125.5*, 117.7,
117.7*, 86.2*, 86.2, 63.7, 58.1, 58.1*, 51.2, 51.1*, 49.0, 43.4*, 43.4,
35.2, 35.1*, 34.0*, 33.9, 32.6*, 32.6, 32.0, 31.9*, 30.1, 26.3, 26.1,
26.0*, 21.1, 18.4, −5.2. IR (Diamond-ATR, neat) νm̃ax: 3349 (br),
2952 (m), 2927 (s), 2855 (m), 1672 (m), 1531 (s), 1472 (m), 1461
(m), 1253 (m), 1200 (m), 1092 (s), 833 (s), 775 (s). HRMS (ESI):
calcd for ([M + H] C27H44NO2Si)
+, 442.3136; found, 442.3125. [α]D
20
= +69.8° (c = 0.57, CH2Cl2).
Synthesis of (5S,6S)-4-Allyl-5-(2-((tert-butyldimethylsilyl)oxy)-
ethyl)-1,1-diethyl-6-methyl-3-((R)-2,6,7,7a-tetrahydro-1H-inden-5-
yl)-1,5,6,7-tetrahydro-1λ4,8λ4-pyrrolo[1,2-c][1,3,2]oxazaborinine
(40). Following the developed procedure,34 an oven-dried vial was
charged with vinylogous amide 36 (40 mg, 90.6 μmol, 1.0 equiv, 3:1
d.r. at C10), pyridinium p-toluenesulfonate (2.3 mg, 9.06 μmol, 10
mol %), triphenylphosphine (3.6 mg, 13.6 μmol, 15 mol %), and
palladium(II) acetate (1.4 mg, 6.34 μmol, 7 mol %). The vial was
flushed with nitrogen and sealed with a septum cap. Toluene (0.5
mL) and a solution of triethylborane (1 M in THF, 137 μL, 137
μmol, 1.5 equiv) were added sequentially, and the vial was placed in a
preheated (80 °C) heating block. After 1 h, the mixture was cooled to
23 °C and concentrated in vacuo, and the crude residue was purified
by flash column chromatography (0%→ 2% ethyl acetate in hexanes)
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to give oxazaborinine 40 (36 mg, 70.7 μmol, 78%, ∼3:1 d.r. at C10)
as an orange oil. TLC (2% ethyl acetate in hexanes): Rf = 0.27 (UV/
KMnO4). Note: Oxazaborinine 40 was obtained as an inseparable
mixture of diastereomers (∼3:1 d.r. at C10). In cases where the
proton or carbon atoms show a double set of signals, the signal of the
minor diastereomer is marked with an asterisk. 1H NMR (700 MHz,
CDCl3): δ 6.42−6.37 (m, 1H), 5.93−5.82 (m, 1H), 5.57 (s, 1H),
5.11−4.98 (m, 2H), 3.76−3.58 (m, 3H), 3.19−3.00 (m, 2H), 2.87−
2.81 (m, 1H), 2.77 (d, J = 10.7 Hz, 1H), 2.66−2.56 (m, 1H), 2.53−
2.28 (m, 4H), 2.21−2.09 (m, 2H), 2.07−2.00 (m, 1H), 1.77−1.70
(m, 1H), 1.51−1.43 (m, 1H), 1.39−1.20 (m, 2H), 0.98 (d, J = 7.1 Hz,
3H), 0.90 (s, 9H), 0.83−0.74 (m, 6H), 0.41−0.28 (m, 4H), 0.08−
0.02 (m, 6H). 13C{1H} NMR (176 MHz, CDCl3): δ 176.42, 176.39*,
175.8, 175.6*, 142.8*, 142.7, 139.20*, 139.18, 137.3, 137.2*, 126.53,
126.51*, 123.8, 123.6*, 114.69, 114.66*, 96.4*, 96.2, 61.1, 58.3, 50.9,
43.1*, 43.1, 34.14*, 34.10, 33.6, 32.2, 32.0, 31.9*, 31.1*, 31.0, 29.9,
28.0, 27.6*, 26.1*, 26.0, 20.7, 18.4, 14.4 (br), 9.33, 9.26, −5.27,
−5.32. 11B NMR (128 MHz, CDCl3): δ 7.33. IR (Diamond-ATR,
neat) νm̃ax: 2928 (s), 2857 (s), 1614 (m), 1501 (m), 1460 (s), 1254
(s), 1095 (s), 1029 (m), 832 (s), 812 (m), 774 (s). HRMS (ESI):
calcd for ([M + H] C31H53BNO2Si)
+, 510.3933; found, 510.3924.
[α]D
20 = −20.6° (c = 0.77, CH2Cl2).
Synthesis of (S)-2-(1-((Trimethylsilyl)ethynyl)cyclopropyl)-
propan-1-ol (50) via Hydroboration−Oxidation. According to
Fürstner’s method,44 isopropenylmagnesium bromide solution (0.5
M in THF, 10.1 mL, 5.07 mmol, 1.3 equiv) was added slowly to a
mixture of tosylate 48 (1.20 g, 3.90 mmol, 1.0 equiv) and iron(III)
acetylacetonate (68.9 mg, 0.20 mmol, 5 mol %) in THF (35 mL) at
−30 °C. After 10 min, the mixture was diluted with saturated aqueous
ammonium chloride solution (50 mL) and diethyl ether (30 mL).
The layers were separated, the aqueous layer was extracted diethyl
ether (2 × 20 mL), and the combined organic extracts were washed
with saturated aqueous sodium chloride solution (40 mL). The
washed organic layer was dried over magnesium sulfate. The dried
solution was filtered, and the filtrate was concentrated in vacuo. The
crude residue was filtered through a short pad of silica, eluting with
diethyl ether (20 mL). The filtrate was concentrated in vacuo to give
spectroscopically pure (1H NMR) alkene 49 (642 mg, 3.60 mmol,
92%) as a yellowish oil that was used in the next step without further
purification. According to Yun’s method,43 a mixture of copper(I)
chloride (3.4 mg, 34.8 μmol, 5 mol %), (S)-DTBM-SEGPHOS (45
mg, 38.2 μmol, 6 mol %), and potassium tert-butoxide (16 mg, 139
μmol, 0.2 equiv) in toluene (0.5 mL) were stirred for 5 min under an
atmosphere of nitrogen at 23 °C. Pinacolborane (121 μL, 835 μmol,
1.2 equiv) was added, and after further 15 min, a solution of alkene 49
(0.13 g, 0.70 mmol, 1.0 equiv) in toluene (0.7 mL) was added. After 9
h, the mixture was filtered through a pad of Celite, eluting with ethyl
acetate (10 mL). The filtrate was concentrated in vacuo, and the
residue was used in the next step without further purification. A
solution of the crude residue in THF (2 mL) and water (2 mL) was
treated with sodium perborate tetrahydrate (0.32 g, 2.07 mmol, 3.0
equiv) at 23 °C. After 5 h, the mixture was diluted with water (10
mL) and ethyl acetate (10 mL). The layers were separated, the
aqueous layer was extracted with ethyl acetate (3 × 5 mL), and the
combined organic extracts were washed with saturated aqueous
sodium chloride solution (10 mL). The washed organic layer was
dried over magnesium sulfate. The dried solution was filtered, and the
filtrate was concentrated in vacuo. The crude residue was purified by
flash column chromatography (20% ethyl acetate in hexanes) to give
alcohol 50 (12 mg, 61.1 μmol, 9%) as a colorless liquid. The 1H,
13C{1H} spectra and HRMS data of 50 were in full agreement with
the values reported for alcohol 50 prepared via the auxiliary-based
approach (see below). Based on the low isolated yield, the
enantiomeric excess of 50 prepared via this hydroboration/oxidation
sequence was not determined.
Synthesis of 2-(1-((Trimethylsilyl)ethynyl)cyclopropyl)acetic Acid
(51). A solution of cyclopropyl(trimethylsilyl)acetylene (13.8 g, 100
mmol, 1.0 equiv) in diethyl ether (170 mL) was treated with n-
butyllithium solution (2.5 M in hexanes, 40 mL, 100 mmol, 1.0 equiv)
at −78 °C. The resulting mixture was then allowed to warm to 23 °C
overnight. After 17 h, the mixture was cooled to −78 °C, whereupon a
solution of freshly condensed oxirane (ca. 6.51 mL, 130 mmol, 1.3
equiv) in diethyl ether (15 mL) was slowly added. The resulting
mixture was then warmed to 0 °C. After 30 min, the mixture was
diluted with saturated aqueous ammonium chloride solution (100
mL). The layers were separated, the aqueous layer was extracted with
diethyl ether (3 × 40 mL), and the combined organic extracts were
washed with saturated aqueous sodium chloride solution (100 mL).
The washed organic layer was dried over sodium sulfate. The dried
solution was filtered, and the filtrate was concentrated in vacuo. The
residue was used in the next step without further purification. A
solution of dimethyl sulfoxide (21.3 mL, 300 mmol, 3.0 equiv) in
dichloromethane (50 mL) was slowly added to oxalyl chloride (17.1
mL, 200 mmol, 2.0 equiv) in dichloromethane (250 mL) at −78 °C.
After 15 min, a solution of the crude alcohol (assuming 100 mmol) in
dichloromethane (75 mL) was slowly added at this temperature. After
15 min, triethylamine (55.5 mL, 400 mmol, 4.0 equiv) was added, and
after further 15 min, the mixture was warmed to 0 °C. After 15 min,
the mixture was diluted with saturated aqueous sodium bicarbonate
solution (200 mL). The layers were separated, the aqueous layer was
extracted with dichloromethane (3 × 20 mL), and the combined
organic extracts were washed with saturated aqueous sodium chloride
solution (100 mL). The washed organic layer was dried over sodium
sulfate. The dried solution was filtered, and the filtrate was
concentrated in vacuo. The residue was used in the next step without
further purification. A solution of the crude aldehyde (assuming 100
mmol) in acetone (340 mL) and water (100 mL) was treated
sequentially with 2-methylbut-2-ene (53 mL, 500 mmol, 5.0 equiv),
sodium phosphate monobasic monohydrate (31.7 g, 230 mmol, 2.3
equiv), and sodium chlorite 27.1 g, 300 mmol, 3.0 equiv) at 0 °C. The
resulting mixture was then warmed to 23 °C. After 2 h, the mixture
was concentrated to approximately half its volume and diluted with
aqueous 1 M hydrogen chloride solution (200 mL) and dichloro-
methane (100 mL). The layers were separated, the aqueous layer was
extracted with dichloromethane (3 × 40 mL), and the combined
organic extracts were washed with saturated aqueous sodium chloride
solution (100 mL). The washed organic layer was dried over sodium
sulfate. The dried solution was filtered, and the filtrate was
concentrated in vacuo. The crude residue was purified by flash
column chromatography (30% → 50% ethyl acetate in hexanes) to
give cyclopropyl acid 51 (17.6 g, 90.0 mmol, 90% over 3 steps) as a
yellow oil. TLC (50% ethyl acetate in hexanes): Rf = 0.40 (KMnO4).
1H NMR (700 MHz, CDCl3): δ 2.44 (s, 2H), 1.07−1.04 (m, 2H),
0.81−0.79 (m, 2H), 0.11 (s, 9H). 13C{1H} NMR (176 MHz, CDCl3):
δ 177.4, 109.9, 81.5, 42.7, 16.0, 9.5, 0.3. IR (Diamond-ATR, neat)
ν ̃max: 3092 (br), 2958 (m), 2163 (m), 1710 (s), 1410 (m), 1248 (s),
867 (m), 836 (s), 758 (s). HRMS (ESI): calcd for ([M + Na]
C10H16NaO2Si)
+, 219.0812; found, 219.0808.
Synthesis of (S)-4-Benzyl-3-(2-(1-((trimethylsilyl)ethynyl)-
cyclopropyl)acetyl)oxazolidin-2-one (S108). A solution of cyclo-
propyl acid 51 (7.84 g, 40.0 mmol, 1.0 equiv) in THF (200 mL) was
treated sequentially with triethylamine (6.65 mL, 48.0 mmol, 1.2
equiv) and pivaloyl chloride (5.41 mL, 44.0 mmol, 1.1 equiv) at −78
°C. The resulting suspension was then warmed to 0 °C. After 30 min,
in a separate flask, a solution of (S)-4-benzyl-2-oxazolidinone (7.80 g,
44.0 mmol, 1.1 equiv) in THF (200 mL) was treated with n-
butyllithium solution (2.5 M in hexanes, 17.6 mL, 44.0 mmol, 1.1
equiv) at −78 °C. After 30 min, the mixture containing the
intermediate anhydride was cooled to −78 °C, whereupon the
mixture containing the lithiated oxazolidinone was added via cannula.
The resulting mixture was warmed to 23 °C. After 50 min, the
mixture was diluted with saturated aqueous sodium bicarbonate
solution (200 mL). The layers were separated, the aqueous layer was
extracted with ethyl acetate (3 × 40 mL), and the combined organic
extracts were washed with saturated aqueous sodium chloride solution
(100 mL). The washed organic layer was dried over magnesium
sulfate. The dried solution was filtered, and the filtrate was
concentrated in vacuo. The crude residue was purified by flash
column chromatography (20% → 30% ethyl acetate in hexanes) to
give oxazolidinone S108 (11.4 g, 32.1 mmol, 80%) as a yellow solid.
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TLC (20% ethyl acetate in hexanes): Rf = 0.25 (UV/KMnO4).
1H
NMR (700 MHz, CDCl3): δ 7.35−7.31 (m, 2H), 7.29−7.26 (m, 1H),
7.24−7.21 (m, 2H), 4.76−4.69 (m, 1H), 4.23−4.19 (m, 1H), 4.18
(dd, J = 9.0, 3.1 Hz, 1H), 3.33 (dd, J = 13.4, 3.2 Hz, 1H), 3.11 (d, J =
17.0 Hz, 1H), 3.01 (d, J = 17.0 Hz, 1H), 2.82 (dd, J = 13.4, 9.5 Hz,
1H), 1.14−1.06 (m, 2H), 0.86−0.77 (m, 2H), 0.11 (s, 9H). 13C{1H}
NMR (176 MHz, CDCl3): δ 170.7, 153.6, 135.4, 129.6, 129.1, 127.5,
110.4, 80.7, 66.4, 55.3, 43.5, 37.9, 16.1, 15.9, 9.5, 0.3. IR (Diamond-
ATR, neat) νm̃ax: 3026 (w), 2958 (m), 2161 (m), 1775 (s), 1705 (s),
1385 (s), 1371 (s), 1248 (m), 1210 (s), 838 (s), 759 (s), 698 (s).
HRMS (ESI): calcd for ([M + Na] C20H25NNaO3Si)
+, 378.1496;
found, 378.1490. [α]D
20 = +76.2° (c = 1.0, CH2Cl2). mp 73−77 °C.
Synthesis of (S)-4-Benzyl-3-((S)-2-(1-((trimethylsilyl)ethynyl)-
cyclopropyl)propanoyl)oxazolidin-2-one (52). A solution of oxazo-
lidinone S108 (6.30 g, 17.7 mmol, 1.0 equiv) in THF (100 mL) was
treated with sodium bis(trimethylsilyl)amide solution (2 M in THF,
10.6 mL, 21.2 mmol, 1.2 equiv) at −78 °C. After 50 min, methyl
iodide (1.65 mL, 26.6 mmol, 1.5 equiv) was added. After 45 min, the
mixture was warmed to 0 °C. After further 15 min, the mixture was
diluted with saturated aqueous sodium bicarbonate solution (100
mL). The layers were separated, the aqueous layer was extracted with
diethyl ether (3 × 40 mL), and the combined organic extracts were
washed with saturated aqueous sodium chloride solution (70 mL).
The washed organic layer was dried over magnesium sulfate. The
dried solution was filtered, and the filtrate was concentrated in vacuo.
The crude residue was purified by flash column chromatography (5%
→ 20% ethyl acetate in hexanes) to give methylated oxazolidinone 52
(5.16 g, 13.9 mmol, 79%) as a yellow solid. TLC (20% ethyl acetate in
hexanes): Rf = 0.32 (UV/KMnO4).
1H NMR (700 MHz, CDCl3): δ
7.35−7.30 (m, 2H), 7.29−7.25 (m, 1H), 7.23−7.20 (m, 2H), 4.73−
4.68 (m, 1H), 4.22−4.14 (m, 2H), 3.47 (q, J = 6.9 Hz, 1H), 3.31 (dd,
J = 13.5, 3.3 Hz, 1H), 2.79 (dd, J = 13.4, 9.5 Hz, 1H), 1.35 (d, J = 7.0
Hz, 3H), 1.00−0.95 (m, 2H), 0.91−0.84 (m, 1H), 0.81−0.75 (m,
1H), 0.14 (s, 9H). 13C{1H} NMR (176 MHz, CDCl3): δ 174.5,
153.4, 135.4, 129.6, 129.0, 127.5, 109.7, 82.1, 66.2, 55.7, 42.8, 37.9,
15.9, 15.7, 15.2, 14.6, 0.4. IR (Diamond-ATR, neat) ν ̃max: 2959 (w),
2159 (m), 1774 (s), 1703 (s), 1382 (s), 1247 (m), 1207 (s), 841 (s),
760 (m), 700 (m). HRMS (ESI): calcd for ([M + Na]
C21H27NNaO3Si)
+, 392.1647; found, 392.1659. [α]D
20 = +25.1° (c =
1.0, CH2Cl2). mp 70−75 °C.
Synthesis of (S)-2-(1-((Trimethylsilyl)ethynyl)cyclopropyl)-
propan-1-ol (50). A solution of methylated oxazolidinone 52 (3.99
g, 10.8 mmol, 1.0 equiv) in THF (100 mL) was treated with methanol
(0.87 mL, 21.8 mmol, 2.0 equiv) and lithium borohydride (470 mg,
21.6 mmol, 2.0 equiv) at 0 °C. After 2 h, the mixture was diluted with
saturated aqueous ammonium chloride solution (50 mL). The layers
were separated, the aqueous layer was extracted with ethyl acetate (3
× 30 mL), and the combined organic extracts were washed with
saturated aqueous sodium chloride solution (30 mL). The washed
organic layer was dried over magnesium sulfate. The dried solution
was filtered, and the filtrate was concentrated in vacuo. The crude
residue was purified by flash column chromatography (5% → 30%
ethyl acetate in hexanes) to give alcohol 50 (2.01 g, 10.3 mmol, 85%)
as a colorless liquid. TLC (20% ethyl acetate in hexanes): Rf = 0.27
(KMnO4).
1H NMR (700 MHz, CDCl3): δ 3.79−3.73 (m, 1H),
3.69−3.62 (m, 1H), 1.79 (br s, 1H), 1.07 (d, J = 6.8 Hz, 3H), 1.01−
0.91 (m, 2H), 0.89−0.84 (m, 1H), 0.75 (ddd, J = 9.2, 6.4, 4.2 Hz,
1H), 0.55 (ddd, J = 9.2, 6.4, 4.2 Hz, 1H), 0.13 (s, 9H). 13C{1H} NMR
(176 MHz, CDCl3): δ 109.6, 82.8, 67.3, 43.4, 16.1, 15.6, 14.8, 14.0,
0.3. IR (Diamond-ATR, neat) νm̃ax: 3330 (br), 2959 (m), 2875 (w),
2157 (m), 1248 (s), 1027 (s), 836 (s), 758 (s). HRMS (ESI): calcd
for ([M + Na] C11H20NaOSi)
+, 219.1176; found, 219.1177. [α]D
20 =
+2.0° (c = 1.0, CH2Cl2).
Synthesis of (S)-2-(1-Ethynylcyclopropyl)propyl Methanesulfo-
nate (53). A solution of alcohol 50 (1.83 g, 9.33 mmol, 1.0 equiv) in
dichloromethane (50 mL) was treated sequentially with triethylamine
(3.23 mL, 23.3 mmol, 2.5 equiv) and methanesulfonyl chloride (867
μL, 11.2 mmol, 1.2 equiv) at 0 °C. After 15 min, the mixture was
diluted with saturated aqueous sodium bicarbonate solution (30 mL).
The layers were separated, the aqueous layer was extracted with
dichloromethane (3 × 20 mL), and the combined organic extracts
were washed with saturated aqueous sodium chloride solution (30
mL). The washed organic layer was dried over magnesium sulfate.
The dried solution was filtered, and the filtrate was concentrated in
vacuo. The residue was used in the next step without further
purification. A solution of the crude silyl mesylate (assuming 9.33
mmol) in THF (50 mL) was treated with TBAF solution (1 M in
THF, 12.1 mL, 12.1 mmol, 1.3 equiv) at 0 °C. After 5 min, the
mixture was diluted with saturated aqueous sodium bicarbonate
solution (30 mL). The layers were separated, the aqueous layer was
extracted with ethyl acetate (3 × 20 mL), and the combined organic
extracts were washed with saturated aqueous sodium chloride solution
(30 mL). The washed organic layer was dried over magnesium sulfate.
The dried solution was filtered, and the filtrate was concentrated in
vacuo. The crude residue was purified by flash column chromatog-
raphy (10% → 20% ethyl acetate in hexanes) to give mesylate 53
(1.81 g, 8.96 mmol, 96% over 2 steps) as a colorless liquid. TLC (30%
ethyl acetate in hexanes): Rf = 0.33 (KMnO4).
1H NMR (700 MHz,
CDCl3): δ 4.35 (dd, J = 9.9, 7.3 Hz, 1H), 4.16 (dd, J = 9.9, 7.0 Hz,
1H), 3.03 (s, 3H), 1.90 (s, 1H), 1.25−1.17 (m, 1H), 1.13 (d, J = 6.9
Hz, 3H), 1.02−0.97 (m, 1H), 0.91 (ddd, J = 9.5, 6.5, 4.4 Hz, 1H),
0.80 (ddd, J = 9.3, 6.5, 4.5 Hz, 1H), 0.58 (ddd, J = 9.3, 6.6, 4.4 Hz,
1H). 13C{1H} NMR (176 MHz, CDCl3): δ 85.7, 73.2, 67.0, 40.6,
37.4, 15.7, 14.7, 14.4, 13.7. IR (Diamond-ATR, neat) νm̃ax: 3281 (m),
2970 (w), 2938 (w), 1458 (w), 1349 (s), 1171 (s), 958 (s), 916 (m),
834 (s). HRMS (ESI): calcd for ([M + Na] C9H14NaO3S)
+,
225.0556; found, 225.0554. [α]D
20 = −17.3° (c = 1.0, CH2Cl2).
Synthesis of (S)-N-Allyl-N-(2-(1-ethynylcyclopropyl)propyl)-2,2,2-
trifluoroacetamide (56). A solution of mesylate 53 (700 mg, 3.46
mmol, 1.0 equiv) in acetonitrile (1.7 mL) was treated with
triethylamine (591 μL, 4.15 mmol, 1.2 equiv), allylamine (3.90 mL,
51.9 mmol, 15 equiv), and sodium iodide (779 mg, 5.19 mmol, 1.5
equiv) at 23 °C. The resulting mixture was heated to 45 °C. After 48
h, the mixture was cooled to 23 °C and then was filtered through a
pad of Celite, eluting with ethyl acetate (100 mL). The filtrate was
concentrated in vacuo, and the residue was used in the next step
without further purification. A solution of the crude secondary amine
(assuming 3.46 mmol) in dichloromethane (35 mL) was treated
sequentially with triethylamine (1.92 mL, 13.8 mmol, 4.0 equiv) and
trifluoroacetic anhydride (963 μL, 6.92 mmol, 2.0 equiv) at −78 °C.
After 15 min, the mixture was diluted with saturated aqueous sodium
bicarbonate solution (50 mL) and warmed to 23 °C. The layers were
separated, the aqueous layer was extracted with diethyl ether (3 × 30
mL), and the combined organic extracts were washed with saturated
aqueous sodium chloride solution (50 mL). The washed organic layer
was dried over magnesium sulfate. The dried solution was filtered, and
the filtrate was concentrated in vacuo. The crude residue was purified
by flash column chromatography (5% ethyl acetate in hexanes) to give
amide 56 (513 mg, 1.98 mmol, 57% over 2 steps) as a colorless oil.
TLC (10% ethyl acetate in hexanes): Rf = 0.49 (KMnO4). Note: As
determined by NMR spectroscopy, amide 56 exists as a mixture of
rotamers (4:1 ratio) at 23 °C. In cases where the proton or carbon
atoms show a double set of signals, the signal of the minor rotamer is
marked with an asterisk. 1H NMR (700 MHz, CDCl3): δ 5.80−5.70
(m, 1H), 5.29−5.18 (m, 2H), 4.43−4.36* (m, 1H), 4.24−4.11 (m,
2H), 3.87* (dd, J = 15.1, 7.0 Hz, 1H), 3.62−3.51 (m, 1H), 3.46−
3.39* (m, 1H), 3.24 (dd, J = 13.6, 9.1 Hz, 1H), 1.93 (s, 1H), 1.36−
1.28 (m, 1H), 1.09−1.02 (m, 3H), 1.01−0.91 (m, 1H), 0.91−0.84
(m, 1H), 0.68−0.61 (m, 1H), 0.58−0.54* (m, 1H), 0.52−0.46 (m,
1H). 13C{1H} NMR (176 MHz, CDCl3): δ 157.1 (q, J = 35.6 Hz),
132.2, 131.3*, 119.0, 118.6*, 116.5 (q, J = 287.9 Hz), 86.5, 85.7*,
67.4*, 67.2, 51.4 (q, J = 3.3 Hz), 51.3, 50.3* (q, J = 2.9 Hz), 50.0*,
41.0*, 38.3, 16.4, 15.74*, 15.71*, 15.41, 15.38*, 15.26, 14.3*, 13.4.
19F NMR (376 MHz, CDCl3): δ −67.48*, −68.52. IR (Diamond-
ATR, neat) νm̃ax: 3310 (w), 2969 (w), 1685 (s), 1454 (m), 1285 (m),
1203 (s), 1169 (s), 1137 (s), 935 (m). HRMS (ESI): calcd for ([M +
Na] C13H16F3NNaO)
+, 282.1076; found, 282.1078. [α]D
20 = −113.1°
(c = 1.0, CH2Cl2).
Synthesis of (S)-2-(1-(3-Oxo-3-((R)-2,6,7,7a-tetrahydro-1H-
inden-5-yl)prop-1-yn-1-yl)cyclopropyl)propyl Methanesulfonate
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(54). A mixture of carboxylic acid 33 (53% ee, 400 mg, 2.44 mmol, 1.2
equiv) in dichloromethane (20 mL) and N,N-dimethylformamide (4
drops) was treated dropwise with oxalyl chloride (243 μL, 2.84 mmol,
1.4 equiv) at 0 °C. The resulting mixture was warmed to 23 °C,
whereupon it turned into a clear, orange solution. After 2 h, the
mixture was concentrated in vacuo to give acid chloride 34 which was
used in the next step without further purification. A flask was charged
wi th ac id ch lor ide 34 (assuming 2 .44 mmol) , b i s -
(triphenylphosphine)palladium(II) dichloride (71.2 mg, 0.10 mmol,
5 mol %), and copper(I) iodide (38.7 mg, 0.20 mmol, 10 mol %). A
solution of mesylate 53 (410 mg, 2.03 mmol, 1.0 equiv) in
triethylamine (17 mL) was then added at 23 °C. After 30 min, the
mixture was diluted with water (40 mL) and diethyl ether (30 mL).
The layers were separated, the aqueous layer was extracted with
diethyl ether (3 × 20 mL), and the combined organic extracts were
washed with saturated aqueous sodium chloride solution (30 mL).
The washed organic layer was dried over magnesium sulfate. The
dried solution was filtered, and the filtrate was concentrated in vacuo.
The crude residue was purified by flash column chromatography
(40% ethyl acetate in hexanes) to give alkynone 54 (685 mg, 1.97
mmol, 97% over two steps, ∼3:1 d.r. at C10) as an orange oil. TLC
(50% ethyl acetate in hexanes): Rf = 0.45 (UV/KMnO4). Note: As a
result of the low enantiomeric purity of carboxylic acid 33 (53% ee),
alkynone 54 was obtained as an inseparable mixture of diastereomers
(∼3:1 d.r. at C10). In cases where the proton or carbon atoms show a
double set of signals, the signal of the minor diastereomer is marked
with an asterisk. 1H NMR (700 MHz, CDCl3): δ 7.49 (br s, 1H), 6.15
(br s, 1H), 4.36 (dd, J = 10.0, 7.3 Hz, 1H), 4.24−4.19 (m, 1H), 3.04
(s, 3H), 2.72−2.61 (m, 2H), 2.49−2.43 (m, 2H), 2.23−2.05 (m, 3H),
1.47−1.37 (m, 1H), 1.37−1.30 (m, 1H), 1.25−1.10 (m, 6H), 1.04−
0.97 (m, 1H), 0.81−0.76 (m, 1H). 13C{1H} NMR (176 MHz,
CDCl3): δ 179.1, 143.2, 140.3, 140.3*, 137.7, 136.11*, 136.10, 95.5,
77.79*, 77.77, 72.8, 43.2, 40.7, 37.5, 33.1, 31.8, 28.9, 23.93, 23.91*,
16.9, 15.17*, 15.16, 15.10*, 15.08. IR (Diamond-ATR, neat) ν ̃max:
2932 (m), 2857 (w), 2198 (s), 1627 (m), 1599 (s), 1352 (s), 1200
(m), 1172 (s), 960 (s), 888 (m), 833 (s). HRMS (ESI): calcd for ([M
+ Na] C19H24NaO4S)
+, 371.1288; found, 371.1282. [α]D
20 = −8.9° (c
= 1.7, CH2Cl2).
Synthesis of 2-((S)-5-Allyl-7-methyl-5-azaspiro[2.4]heptan-4-yli-
dene)-1-((R)-2,6,7,7a-tetrahydro-1H-inden-5-yl)ethan-1-one (55). A
solution of alkynone 54 (2.09 g, 6.03 mmol, 1.0 equiv, ∼3:1 d.r. at
C10) in acetonitrile (60 mL) was treated with triethylamine (1.00
mL, 7.24 mmol, 1.2 equiv) and allylamine (3.17 mL, 42.2 mmol, 7.0
equiv), and the resulting mixture was heated to 60 °C. After 26 h, the
mixture was cooled to 23 °C and concentrated in vacuo. The crude
residue was purified by flash column chromatography (40% → 50%
ethyl acetate in hexanes) to give cyclopropyl vinylogous amide 55
(470 mg, 1.52 mmol, 25%, ∼3:1 d.r. at C10) as a dark red oil. TLC
(50% ethyl acetate in hexanes): Rf = 0.30 (UV/KMnO4). Note:
Cyclopropyl vinylogous amide 55 was obtained as an inseparable
mixture of diastereomers (∼3:1 d.r. at C10). In cases where the
proton or carbon atoms show a double set of signals, the signal of the
minor diastereomer is marked with an asterisk. Furthermore, 55
shows signal broadening in the 1H and 13C{1H} NMR spectra,
presumably because of hindered rotation. 1H NMR (700 MHz,
CDCl3): δ 6.92 (s, 1H), 5.91−5.79 (m, 1H), 5.72 (s, 1H), 5.22−5.07
(m, 2H), 4.61 (br s, 1H), 4.43 (br s, 2H), 3.69 (t, J = 9.1 Hz, 1H),
3.18−3.09 (m, 1H), 2.69−2.51 (m, 2H), 2.43−2.33 (m, 2H), 2.33−
2.21 (m, 1H), 2.18−2.09 (m, 2H), 2.09−1.99 (m, 1H), 1.43−1.31
(m, 1H), 1.19 (qd, J = 12.5, 4.8 Hz, 1H), 1.04−0.76 (m, 6H), 0.73
(br s, 1H). 13C{1H} NMR (176 MHz, CDCl3): δ 187.4, 168.0, 143.9,
143.0, 133.2, 128.5, 125.9, 117.51, 117.48*, 81.6, 59.7, 54.4, 43.4,
34.6, 33.5, 32.6, 31.9, 30.0, 26.32, 26.28*, 15.9, 14.4, 11.4. IR
(Diamond-ATR, neat) ν ̃max: 2922 (m), 2834 (m), 1604 (s), 1571
(m), 1523 (s), 1451 (m), 1427 (m), 1268 (m), 1199 (s), 914 (m).
HRMS (ESI): calcd for ([M + H], C21H28NO)
+: 310.2165; found,
310.2164. [α]D
20 = +22.9° (c = 1.0, CH2Cl2).
Alternative Synthesis of 2-((S)-5-Allyl-7-methyl-5-azaspiro[2.4]-
heptan-4-ylidene)-1-((R)-2,6,7,7a-tetrahydro-1H-inden-5-yl)ethan-
1-one (55). A mixture of carboxylic acid 33 (53% ee, 320 mg, 1.95
mmol, 1.1 equiv) in dichloromethane (17 mL) and N,N-
dimethylformamide (3 drops) was treated dropwise with oxalyl
chloride (190 μL, 2.21 mmol, 1.3 equiv) at 0 °C. The resulting
mixture was warmed to 23 °C, whereupon it turned into a clear,
orange solution. After 2 h, the mixture was concentrated in vacuo to
give acid chloride 34 which was used in the next step without further
purification. A flask was charged with acid chloride 34 (assuming 1.95
mmol), bis(triphenylphosphine)palladium(II) dichloride (62.1 mg,
88.5 μmol, 5 mol %), and copper(I) iodide (33.7 mg, 0.18 mmol, 10
mol %). A solution of amide 56 (459 mg, 1.77 mmol, 1.0 equiv) in
triethylamine (15 mL) was then added at 23 °C. After 30 min, the
mixture was diluted with water (40 mL) and diethyl ether (30 mL).
The layers were separated, the aqueous layer was extracted with
diethyl ether (3 × 20 mL), and the combined organic extracts were
washed with saturated aqueous sodium chloride solution (30 mL).
The washed organic layer was dried over magnesium sulfate. The
dried solution was filtered, and the filtrate was concentrated in vacuo.
The crude residue was used in the next step without further
purification. The crude alkynone (assuming 1.77 mmol) in methanol
(15 mL), THF (5 mL) and water (5 mL) was treated with potassium
carbonate (734 mg, 5.31 mmol, 3.0 equiv) at 0 °C. The resulting
mixture was then warmed to 23 °C. After 18 h, the mixture was
diluted with saturated aqueous sodium bicarbonate solution (50 mL).
The layers were separated, the aqueous layer was extracted with ethyl
acetate (4 × 40 mL), and the combined organic extracts were washed
with saturated aqueous sodium chloride solution (50 mL). The
washed organic layer was dried over magnesium sulfate. The dried
solution was filtered, and the filtrate was concentrated in vacuo. The
crude residue was purified by flash column chromatography (20% →
50% ethyl acetate in hexanes) to give cyclopropyl vinylogous amide
55 (218 mg, 0.71 mmol, 40% over three steps, ∼3:1 d.r. at C10) as a
yellow oil. The characterization data of 55 were in full agreement with
the values reported above.
Synthesis of (S)-4′-Allyl-1′,1′-diethyl-6′-methyl-3′-((R)-2,6,7,7a-
tetrahydro-1H-inden-5-yl)-6′,7′-dihydro-1′H-1′λ4,8′λ4-spiro-
[cyclopropane-1,5′-pyrrolo[1,2-c][1,3,2]oxazaborinine] (47). Fol-
lowing the developed procedure,34 an oven-dried vial was charged
with a magnetic stirring bar, cyclopropyl vinylogous amide 55 (100
mg, 324 μmol, 1.0 equiv, ∼3:1 d.r. at C10), pyridinium p-
toluenesulfonate (8.1 mg, 32.4 μmol, 10 mol %), triphenylphosphine
(8.5 mg, 32.4 μmol, 10 mol %), and palladium(II) acetate (3.6 mg,
16.2 μmol, 5 mol %). The vial was flushed with nitrogen and sealed
with a septum cap. Toluene (1.5 mL) and a solution of triethylborane
(1 M in THF, 486 μL, 486 μmol, 1.5 equiv) were added sequentially,
and the vial was placed in a preheated (80 °C) heating block. After 1
h, the mixture was cooled to 23 °C and concentrated in vacuo, and
the crude residue was purified by flash column chromatography (1%
→ 3% ethyl acetate in hexanes) to give cyclopropyl oxazaborinine 47
(74 mg, 196 μmol, 60%, ∼3:1 d.r. at C10) as a yellow oil. TLC (4%
ethyl acetate in hexanes): Rf = 0.48 (UV/KMnO4). Note: Cyclopropyl
oxazaborinine 47 was obtained as an inseparable mixture of
diastereomers (∼3:1 d.r. at C10). In cases where the proton or
carbon atoms show a double set of signals, the signal of the minor
diastereomer is marked with an asterisk. 1H NMR (700 MHz,
CDCl3): δ 6.29 (s, 1H), 5.91−5.80 (m, 1H), 5.53 (s, 1H), 5.10−5.02
(m, 2H), 3.71 (dd, J = 13.6, 7.4 Hz, 1H), 3.17 (dd, J = 13.6, 4.7 Hz,
1H), 2.81−2.73 (m, 1H), 2.64−2.55 (m, 2H), 2.41−2.29 (m, 4H),
2.15−2.09 (m, 1H), 2.05−1.99 (m, 1H), 1.99−1.93 (m, 1H), 1.39−
1.22 (m, 4H), 0.97−0.88 (m, 4H), 0.85−0.74 (m, 7H), 0.41−0.32
(m, 4H). 13C{1H} NMR (176 MHz, CDCl3): δ 176.2, 176.1*, 173.8,
142.6, 139.5, 137.6, 126.1, 123.13, 123.08*, 115.2, 95.5, 56.8, 43.1*,
43.1, 37.50*, 37.49, 35.83, 35.82*, 32.2, 31.94, 31.93*, 29.9, 29.19*,
29.18, 28.2, 28.1*, 16.68, 16.66*, 14.0, 13.9*, 10.8, 9.39*, 9.37, 9.36,
9.35*. 11B NMR (128 MHz, CDCl3): δ 6.02. IR (Diamond-ATR,
neat) νm̃ax: 2929 (m), 2859 (m), 1584 (s), 1482 (s), 1449 (s), 1330
(m), 1300 (s), 1200 (s), 1083 (m), 1053 (m), 911 (s). HRMS (ESI):
calcd for ([M + Na] C25H36BNNaO)
+, 400.2782; found, 400.2784.
[α]D
20 = −14.8° (c = 1.0, CH2Cl2).
Synthesis of (2S,7aR)-4-Al ly l -2-methyl-1,2,7 ,7A,8,9-
hexahydrospiro[cyclopenta[h]pyrrolo[1,2-a]quinoline-3,1′-cyclo-
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propan]-5(6H)-one (58). A solution of cyclopropyl oxazaborinine 47
(30.7 mg, 81.3 μmol, 1.0 equiv, ∼3:1 d.r. at C10) in ethanol (1 mL)
was treated with 4-(dimethylamino)pyridine (99.4 mg, 813 μmol, 10
equiv), and the resulting mixture was heated to 80 °C. After 20 h, the
mixture was cooled to 23 °C and then was filtered through a short pad
of silica, eluting with ethyl acetate (20 mL). The filtrate was
concentrated in vacuo, and the residue was used in the next step
without further purification. A solution of the crude α-allyl vinylogous
amide (assuming 81.3 μmol) in N,N-dimethylformamide (0.1 mL)
and N,O-bis(trimethylsilyl)acetamide (1 mL) was heated to 130 °C.
After 24 h, the mixture was cooled to 23 °C and concentrated in
vacuo. The crude residue was prepurified by flash column
chromatography (5% methanol in dichloromethane) to give a
brown residue (ca. 25 mg) that was further purified by preparative
TLC (2% methanol in dichloromethane) to give 4-pyridone 58 (2.5
mg, 8.14 μmol, 10%, ∼1.5:1 d.r. at C10) as a yellow oil. TLC (5%
methanol in dichloromethane): Rf = 0.20 (UV/KMnO4). Note:
Pyridone 58 was obtained as an inseparable mixture of diastereomers
(∼1.5:1 d.r. at C10). In cases where the proton or carbon atoms show
a double set of signals, the signal of the minor diastereomer is marked
with an asterisk. 1H NMR (700 MHz, CDCl3): δ 6.20−6.14 (m, 1H),
5.98−5.88 (m, 1H), 5.00−4.91 (m, 2H), 4.47−4.38 (m, 1H), 3.99−
3.93* (m, 1H), 3.86−3.79* (m, 1H), 3.41−3.29 (m, 1H), 3.04−2.83
(m, 3H), 2.62−2.56 (m, 2H), 2.56−2.44 (m, 2H), 2.27−2.18 (m,
1H), 2.16−2.08 (m, 1H), 1.95−1.87* (m, 1H), 1.69−1.62 (m, 1H),
1.56−1.48 (m, 1H), 1.37 (app qd, J = 12.6, 5.5 Hz, 1H), 1.19−1.12
(m, 1H), 1.10 (t, J = 8.3 Hz, 1H), 1.01* (d, J = 7.0 Hz, 2H), 0.98−
0.87 (m, 4H), 0.81−0.73 (m, 1H). 13C{1H} NMR (176 MHz,
CDCl3): δ 177.4, 151.8, 150.6*, 138.5*, 138.3, 137.96, 137.95*,
137.5, 137.4*, 131.1, 124.49*, 124.46, 118.7*, 118.4, 114.5, 114.4*,
58.8, 58.2*, 46.3, 46.2*, 38.8, 36.0, 33.4, 31.7*, 31.0*, 30.8, 29.9*,
29.5, 29.4*, 26.8, 26.7*, 24.62*, 24.56, 17.7*, 15.3*, 13.5, 10.6, 10.5,
10.0*. IR (Diamond-ATR, neat) ν ̃max: 3350 (br), 2924 (m), 1600 (s),
1534 (s), 1489 (s), 1434 (m), 1242 (m), 1224 (m), 906 (m). HRMS
(ESI): calcd for ([M + H] C21H26NO)
+, 308.2009; found, 308.2012.
[α]D
20 = −18.0° (c = 0.8, CH2Cl2).
Synthesis of (S)-2-Bromo-N-(1-phenylethyl)prop-2-en-1-amine
(63). A solution of (S)-(−)-1-phenylethylamine (17.9 mL, 139
mmol, 1.8 equiv) in THF (250 mL) was treated with potassium
carbonate (11.8 g, 85.0 mmol, 1.1 equiv) at 23 °C. 2,3-
Dibromopropene (8.00 mL, 77.3 mmol, 1.0 equiv) was then added
over a 30 min period. After the end of addition, the resulting mixture
was warmed to 66 °C. After 23 h, the mixture was diluted with water
(150 mL). The layers were separated, the aqueous layer was extracted
with diethyl ether (3 × 50 mL), and the combined organic extracts
were washed with saturated aqueous sodium chloride solution (2 ×
100 mL). The washed organic layer was dried over sodium sulfate.
The dried solution was filtered and the filtrate was concentrated in
vacuo. The crude residue was purified by flash column chromatog-
raphy (10%→ 20% ethyl acetate in hexanes) to give vinyl bromide 63
(17.9 g, 74.9 mmol, 97%) as a yellow oil. TLC (20% ethyl acetate in
hexanes): Rf = 0.41 (UV/KMnO4).
1H NMR (700 MHz, CDCl3): δ
7.39−7.34 (m, 4H), 7.32−7.26 (m, 1H), 5.71 (br s, 1H), 5.59 (d, J =
1.8 Hz, 1H), 3.84 (q, J = 6.6 Hz, 1H), 3.40 (d, J = 15.2 Hz, 1H), 3.30
(d, J = 15.2 Hz, 1H), 1.83 (br s, 1H), 1.40 (d, J = 6.7 Hz, 3H).
13C{1H} NMR (176 MHz, CDCl3): δ 144.9, 133.9, 128.6, 127.2,
127.0, 117.8, 55.7, 55.2, 24.4. IR (Diamond-ATR, neat) νm̃ax: 2961
(w), 2922 (m), 2832 (w), 1625 (m), 1492 (m), 1449 (s), 1370 (m),
1123 (s), 891 (s), 760 (s), 698 (s). HRMS (ESI): calcd for ([M + H]
C11H15
79BrN)+, 240.0382; found, 240.0380. [α]D
20 = −37.4° (c = 1.0,
CH2Cl2).
Synthesis of tert-Butyl (R)-3-((2-bromoallyl) ((S)-1-phenylethyl)-
amino)pent-4-enoate (65). A solution of vinyl bromide 63 (2.95 g,
12.3 mmol, 1.1 equiv) in THF (12 mL) was treated with n-
butyllithium solution (1.6 M in hexanes, 7.00 mL, 11.2 mmol, 1.0
equiv) at −78 °C. After 3 min, a solution of dienoate 6466 (1.90 g,
12.3 mmol, 1.1 equiv) in THF (6 mL) was added. After 20 min, the
mixture was diluted with saturated aqueous ammonium chloride
solution (20 mL) and warmed to 23 °C. The layers were separated,
the aqueous layer was extracted with diethyl ether (3 × 20 mL), and
the combined organic extracts were washed with saturated aqueous
sodium chloride solution (50 mL). The washed organic layer was
dried over sodium sulfate. The dried solution was filtered, and the
filtrate was concentrated in vacuo. The crude residue was purified by
flash column chromatography (1%→ 2% ethyl acetate in hexanes) to
give ester 65 (2.91 g, 7.39 mmol, 66%) as a yellow oil. TLC (10%
ethyl acetate in hexanes): Rf = 0.50 (UV/KMnO4).
1H NMR (700
MHz, CDCl3): δ 7.39−7.36 (m, 2H), 7.33−7.28 (m, 2H), 7.25−7.21
(m, 1H), 6.02 (s, 1H), 5.86−5.79 (m, 1H), 5.54 (s, 1H), 5.16−5.10
(m, 2H), 4.03 (q, J = 6.9 Hz, 1H), 3.86−3.80 (m, 1H), 3.39−3.28 (m,
2H), 2.39−2.26 (m, 2H), 1.41−1.40 (m, 3H), 1.37 (s, 9H). 13C{1H}
NMR (176 MHz, CDCl3): δ 171.1, 143.9, 138.0, 134.5, 128.3, 127.8,
127.1, 117.3, 116.5, 80.4, 58.5, 57.8, 55.2, 38.4, 28.2, 18.6. IR
(Diamond-ATR, neat) ν ̃max: 2975 (m), 2931 (w), 1725 (s), 1366 (s),
1144 (s), 1085 (m), 918 (s), 892 (s), 733 (s), 699 (s). HRMS (ESI):
calcd for ([M + Na] C20H28
79BrNNaO2)
+, 416.1196; found,
416.1196. [α]D
20 = +24.5° (c = 1.0, CH2Cl2).
Synthesis of tert-Butyl (S)-3-((2-bromoallyl) ((S)-1-phenylethyl)-
amino)-2-methylenepent-4-enoate (66). n-Butyllithium solution
(2.5 M in hexanes, 6.84 mL, 17.1 mmol, 2.5 equiv) was added
dropwise to a solution of DIPA (2.49 mL, 17.8 mmol, 2.6 equiv) in
THF (20 mL) at −78 °C. After 15 min, a solution of ester 65 (2.40 g,
6.84 mmol, 1.0 equiv) in THF (15 mL) was added via a syringe to the
freshly prepared lithium diisopropylamide solution at −78 °C. After
30 min, 2-methoxyethoxymethyl chloride (1.56 mL, 13.7 mmol, 2.0
equiv) was added, and the resulting mixture was warmed to 0 °C.
After 30 min, potassium tert-butoxide solution (1 M in THF, 13.7 mL,
13.7 mmol, 2.0 equiv) was added, and the resulting mixture was
warmed to 23 °C. After 1 h, the mixture was diluted with saturated
aqueous ammonium chloride solution (50 mL). The layers were
separated, the aqueous layer was extracted with diethyl ether (3 × 30
mL), and the combined organic extracts were washed with saturated
aqueous sodium chloride solution (50 mL). The washed organic layer
was dried over sodium sulfate. The dried solution was filtered, and the
filtrate was concentrated in vacuo. The crude residue was purified by
flash column chromatography (3%→ 5% ethyl acetate in hexanes) to
give enoate 66 (1.39 g, 3.42 mmol, 50%) as a yellow oil. TLC (10%
ethyl acetate in hexanes): Rf = 0.56 (UV/KMnO4).
1H NMR (700
MHz, CDCl3): δ 7.33−7.27 (m, 4H), 7.24−7.21 (m, 1H), 6.16 (d, J =
1.3 Hz, 1H), 6.07−6.03 (m, 1H), 5.90 (ddd, J = 17.1, 10.2, 8.1 Hz,
1H), 5.76 (br s, 1H), 5.49 (q, J = 1.5 Hz, 1H), 5.16−5.06 (m, 2H),
4.37 (d, J = 8.2 Hz, 1H), 4.10 (q, J = 6.9 Hz, 1H), 3.47 (d, J = 17.2
Hz, 1H), 3.31 (d, J = 17.2 Hz, 1H), 1.46 (s, 9H), 1.40 (d, J = 6.9 Hz,
3H). 13C{1H} NMR (176 MHz, CDCl3): δ 166.3, 143.3, 143.0, 137.0,
135.0, 128.2, 127.1, 124.8, 117.7, 116.9, 80.9, 63.1, 58.0, 55.1, 28.2,
18.5. IR (Diamond-ATR, neat) ν ̃max: 2975 (m), 1711 (s), 1366 (s),
1270 (m), 1254 (m), 1142 (s), 1101 (m), 1083 (m), 909 (s), 732 (s),
699 (s). HRMS (ESI): calcd for ([M + H] C21H29
79BrNO2)
+,
406.1379; found, 406.1376. [α]D
20 = +20.9° (c = 1.0, CH2Cl2).
Synthesis of tert-Butyl (3aS,6R,6aS)-3-methylene-1-((S)-1-
phenylethyl)octahydrocyclopenta[b]pyrrole-6-carboxylate (70)
and tert-Butyl (3aS,6S,6aS)-3-methylene-1-((S)-1-phenylethyl)-
octahydrocyclopenta[b]pyrrole-6-carboxylate (C8-epi-70). Accord-
ing to Molander’s method,50 a flask was charged with enoate 66 (1.00
g, 2.47 mmol, 1.0 equiv), tetrahydroxydiboron (266 mg, 2.96 mmol,
1.2 equiv), copper(I) chloride (12.2 mg, 124 μmol, 5 mol %), sodium
tert-butoxide (71.2 mg, 741 μmol, 0.3 equiv), and (2-biphenyl)-
dicyclohexylphosphine (43.3 mg, 124 μmol, 5 mol %). Ethanol (25
mL) was then added, and the mixture was stirred vigorously at 23 °C.
After 3 h, the mixture was filtered through a pad of Celite, eluting with
ethyl acetate (70 mL). The filtrate was concentrated in vacuo, and the
residue was used in the next step without further purification. A
solution of the crude boronic acid 67 (assuming 2.47 mmol) in N2-
sparged (30 min) THF (30 mL) and aqueous 2 M sodium carbonate
solution (5.5 mL) was treated with tetrakis(triphenylphosphine)-
palladium(0) (199 mg, 173 μmol, 7 mol %), and the resulting mixture
was heated to 70 °C. After 17 h, the mixture was cooled to 23 °C and
diluted with saturated aqueous sodium bicarbonate solution (20 mL).
The layers were separated, the aqueous layer was extracted with
diethyl ether (3 × 30 mL), and the combined organic extracts were
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washed with saturated aqueous sodium chloride solution (30 mL).
The washed organic layer was dried over magnesium sulfate. The
dried solution was filtered, and the filtrate was concentrated in vacuo.
The crude residue was purified by flash column chromatography (5%
→ 10% ethyl acetate in hexanes) to give, in order of elution, major
bicycle 70 (218 mg, 666 μmol, 27%, yellow solid) and minor bicycle
C8-epi-70 (24.2 mg, 74.1 μmol, 3%, yellow oil). Data for major
bicycle 70: TLC (10% ethyl acetate in hexanes): Rf = 0.39 (KMnO4).
1H NMR (500 MHz, CDCl3): δ 7.33−7.26 (m, 4H), 7.25−7.20 (m,
1H), 4.62−4.52 (m, 2H), 3.93−3.85 (m, 1H), 3.68 (q, J = 6.9 Hz,
1H), 3.41−3.30 (m, 1H), 3.14 (dq, J = 14.8, 2.1 Hz, 1H), 2.91−2.84
(m, 1H), 2.54 (dd, J = 12.3, 7.1 Hz, 1H), 2.47−2.37 (m, 1H), 2.29−
2.19 (m, 1H), 1.79−1.70 (m, 1H), 1.52 (s, 9H), 1.45−1.41 (m, 3H),
1.31−1.21 (m, 1H).13C{1H} NMR (176 MHz, CDCl3): δ 174.3,
147.2, 143.6, 128.2, 127.8, 126.9, 101.3, 80.3, 76.2, 64.1, 63.4, 52.2,
43.8, 32.7, 28.5, 22.7, 19.9. IR (Diamond-ATR, neat) ν ̃max: 2973 (m),
2934 (w), 1720 (s), 1366 (s), 1144 (s), 701 (s). HRMS (ESI): calcd
for ([M + H] C21H30NO2)
+, 328.2271; found, 328.2274. [α]D
20 =
−56.6° (c = 1.0, CH2Cl2). mp 65−70 °C. Data for minor bicycle C8-
epi-70: TLC (20% ethyl acetate in hexanes): Rf = 0.38 (UV/KMnO4).
1H NMR (700 MHz, CDCl3): δ 7.33−7.28 (m, 4H), 7.24−7.21 (m,
1H), 4.64−4.52 (m, 2H), 3.72−3.64 (m, 1H), 3.50 (q, J = 6.6 Hz,
1H), 3.14 (dq, J = 15.0, 2.3 Hz, 1H), 2.92 (dd, J = 11.9, 9.3 Hz, 1H),
2.89−2.79 (m, 1H), 2.68−2.53 (m, 2H), 2.21−2.13 (m, 1H), 1.74−
1.68 (m, 1H), 1.46 (s, 9H), 1.45−1.42 (m, 1H), 1.31 (d, J = 6.6 Hz,
3H). 13C{1H} NMR (176 MHz, CDCl3): δ 176.1, 146.5, 144.6, 128.3,
127.7, 127.0, 101.7, 80.5, 75.4, 64.2, 63.5, 57.0, 46.5, 36.0, 28.2, 22.8,
20.8. IR (Diamond-ATR, neat) ν ̃max: 2972 (m), 2875 (w), 1721 (s),
1584 (m), 1366 (s), 1134 (s), 765 (m), 737 (m), 700 (s). HRMS
(ESI): calcd for ([M + H] C21H30NO2)
+, 328.2271; found, 328.2277.
[α]D
20 = −40.8° (c = 1.0, CH2Cl2).
Synthesis of tert-Butyl (1R,2S)-2-((2-Bromoallyl) ((S)-1-
phenylethyl)amino)cyclopent-3-ene-1-carboxylate (71). n-Butyl-
lithium solution (1.6 M in hexanes, 2.62 mL, 4.20 mmol, 1.5 equiv)
was added dropwise to a solution of DIPA (629 μL, 4.48 mmol, 1.6
equiv) in THF (7 mL) at −78 °C. After 15 min, a solution of ester 65
(1.10 g, 2.80 mmol, 1.0 equiv) in THF (7 mL) was added via syringe
to the freshly prepared lithium diisopropylamide solution at −78 °C.
After 30 min, allyl bromide (483 μL, 5.59 mmol, 2.0 equiv) was
added, and after further 15 min, the mixture was warmed to 0 °C.
After 30 min, the mixture was diluted with saturated aqueous
ammonium chloride solution (20 mL). The layers were separated, the
aqueous layer was extracted with diethyl ether (3 × 20 mL), and the
combined organic extracts were washed with saturated aqueous
sodium chloride solution (30 mL). The washed organic layer was
dried over magnesium sulfate. The dried solution was filtered, and the
filtrate was concentrated in vacuo. The residue was filtered through a
short pad of silica, eluting with 5% ethyl acetate in hexanes (200 mL).
The filtrate was concentrated in vacuo, and the residue was used in
the next step without further purification. A solution of the crude α-
allylated ester (assuming 2.80 mmol) in N2-sparged (30 min)
dichloromethane (60 mL) was treated with Hoveyda−Gubbs catalyst
2nd generation (87.7 mg, 140 μmol, 5 mol %) at 23 °C, and the
mixture was heated to 40 °C. After 1 h, the mixture was cooled to 23
°C and was concentrated in vacuo. The crude residue was purified by
flash column chromatography (5% ethyl acetate in hexanes) to give
cyclopentene 71 (816 mg, 2.01 mmol, 72%) as a yellow oil. TLC
(20% ethyl acetate in hexanes): Rf = 0.55 (UV/KMnO4).
1H NMR
(700 MHz, CDCl3): δ 7.41−7.38 (m, 2H), 7.32−7.28 (m, 2H),
7.24−7.20 (m, 1H), 6.11 (br s, 1H), 5.79−5.75 (m, 1H), 5.56 (br s,
1H), 5.55−5.51 (m, 1H), 4.30−4.26 (m, 1H), 4.00 (q, J = 6.8 Hz,
1H), 3.36 (d, J = 16.9 Hz, 1H), 3.28 (d, J = 16.9 Hz, 1H), 2.72−2.67
(m, 1H), 2.61−2.55 (m, 1H), 2.41−2.36 (m, 1H), 1.40 (d, J = 6.9 Hz,
3H), 1.34 (s, 9H). 13C{1H} NMR (176 MHz, CDCl3): δ 175.3,
144.3, 135.2, 131.9, 128.4, 127.9, 126.9, 116.9, 80.2, 69.8, 59.6, 54.8,
47.2, 36.3, 28.1, 18.6. IR (Diamond-ATR, neat) ν ̃max: 2975 (m), 2931
(w), 1720 (s), 1626 (w), 1452 (m), 1366 (s), 1144 (s), 733 (s), 699
(s). HRMS (ESI): calcd for ([M + H] C21H29
79BrNO2)
+, 406.1376;
found, 406.1351. [α]D
20 = +73.6° (c = 1.0, CH2Cl2).
Synthesis of tert-Butyl (3aR,6R,6aS)-3-Methylene-1-((S)-1-phe-
nylethyl)-1,2,3,3A,6,6a-hexahydrocyclopenta[b]pyrrole-6-carboxy-
late (73). A solution of cyclopentene 71 (800 mg, 1.97 mmol, 1.0
equiv) in N2-sparged (30 min) acetonitrile (10 mL) was sequentially
treated with triphenylphosphine (104 mg, 395 μmol, 0.2 equiv),
triethylamine (574 μL, 4.15 mmol, 2.1 equiv), and palladium(II)
acetate (44.3 mg, 197 μmol, 0.1 equiv), and the resulting mixture was
heated to 80 °C. After 2.5 h, the dark red mixture was cooled to 23
°C, and then was diluted with saturated aqueous sodium bicarbonate
solution (30 mL) and diethyl ether (30 mL). The layers were
separated, the aqueous layer was extracted with diethyl ether (3 × 30
mL), and the combined organic extracts were washed with saturated
aqueous sodium chloride solution (50 mL). The washed organic layer
was dried over magnesium sulfate. The dried solution was filtered, and
the filtrate was concentrated in vacuo. The crude residue was purified
by flash column chromatography (5% → 10% ethyl acetate in
hexanes) to give diene 73 (352 mg, 1.08 mmol, 55%) as a dark red
solid. TLC (20% ethyl acetate in hexanes): Rf = 0.44 (UV/KMnO4).
1H NMR (700 MHz, CDCl3): δ 7.32−7.30 (m, 4H), 7.26−7.23 (m,
1H), 5.81 (dt, J = 5.6, 2.2 Hz, 1H), 5.65−5.62 (m, 1H), 4.89 (br s,
1H), 4.85 (br s, 1H), 3.81−3.77 (m, 1H), 3.77−3.71 (m, 2H), 3.63−
3.60 (m, 1H), 3.33 (d, J = 12.9 Hz, 1H), 3.01 (d, J = 12.8 Hz, 1H),
1.46 (s, 9H), 1.44 (d, J = 6.9 Hz, 3H). 13C{1H} NMR (176 MHz,
CDCl3): δ 173.0, 149.3, 142.8, 134.6, 128.3, 128.0, 127.5, 127.2,
105.4, 80.8, 68.1, 62.7, 59.7, 56.9, 54.6, 28.3, 22.5. IR (Diamond-
ATR, neat) νm̃ax: 2974 (m), 2774 (w), 1721 (s), 1453 (m), 1366 (s),
1258 (m), 1137 (s), 702 (s). HRMS (ESI): calcd for ([M + H]
C21H28NO2)
+, 326.2115; found, 326.2130. [α]D
20 = +195.3 (c = 1.0,
CH2Cl2). mp 45−50 °C.
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